UPSC IAS Civil Services — Life Sciences Optional
100% Complete Notes
Paper I & Paper II
Comprehensive coverage of every UPSC-prescribed topic — molecules, cell biology, genetics, physiology, ecology, evolution, developmental biology, and applied biology.
Molecular BiologyCell BiologyGenetics & InheritancePlant PhysiologyAnimal PhysiologyEcology & EvolutionApplied BiologyMethods in Biology
Unit 1 — Paper I
U1 Molecules and Their Interaction Relevant to Biology
1.1 Structure of Atoms, Molecules and Chemical Bonds
- Atomic structure: nucleus (protons + neutrons) + electrons in orbitals; atomic number = protons; mass number = protons + neutrons
- Chemical bonds: Covalent (shared electrons — strongest; C–C, C–H, C–N, C–O in biomolecules); Ionic (electrostatic; NaCl; important in enzyme active sites); Hydrogen bonds (O–H···O, N–H···O; weaker individually but cumulative strength in DNA, proteins); Van der Waals (induced dipole; weakest; important in protein folding, enzyme-substrate complementarity)
- Hydrophobic interactions: non-polar groups cluster away from water; drives protein folding, membrane formation, lipid bilayer
- Covalent vs non-covalent bonds: biological systems use non-covalent bonds for reversible interactions (enzyme-substrate, antigen-antibody, receptor-ligand)
1.2 Biomolecules — Structure and Function
Carbohydrates
- Empirical formula (CH₂O)n; monosaccharides (glucose, fructose, galactose, ribose, deoxyribose); anomeric carbon → α and β forms; ring closure (Haworth projection)
- Disaccharides: Sucrose (α-glucose + β-fructose; 1→2 glycosidic bond — non-reducing); Lactose (β-galactose + glucose; 1→4 bond — reducing); Maltose (glucose + glucose; α-1,4 — reducing)
- Polysaccharides: Starch (amylose — unbranched α-1,4 links; amylopectin — α-1,4 + α-1,6 branches); Glycogen (highly branched, α-1,6 every 8–10 glucose — rapid mobilisation); Cellulose (β-1,4 — unbranched; structural; humans cannot digest — dietary fibre); Chitin (β-1,4 N-acetylglucosamine — fungal cell walls, arthropod exoskeleton)
- Glycoproteins and glycolipids: carbohydrate covalently attached to protein/lipid; cell recognition, blood group antigens (ABO — N-acetylgalactosamine, galactose on red cell surface)
Lipids
- Fatty acids: carboxyl head + hydrocarbon chain; saturated (no double bonds — palmitic, stearic; solid at RT); unsaturated (1+ double bonds — oleic [mono], linoleic, linolenic [poly]; cis configuration → kink → lower melting point)
- Triacylglycerols (triglycerides): glycerol + 3 fatty acids; energy storage (9 kcal/g); adipose tissue
- Phospholipids: glycerol + 2 fatty acids + phosphate head group; amphipathic → form bilayers; examples: phosphatidylcholine (lecithin), phosphatidylinositol (PIP₂ signalling), phosphatidylserine (cell death signal on outer leaflet)
- Sterols: fused 4-ring structure; Cholesterol (membrane fluidity regulator — stiffens at high temp, prevents solidification at low temp; precursor for steroid hormones, bile acids, vitamin D); Phytosterols (plant); Ergosterol (fungal)
- Sphingolipids: sphingosine backbone; sphingomyelin (myelin sheath); cerebrosides and gangliosides (neural function; ABO antigens on red cells are glycolipids)
- Isoprenoids/Terpenes: isoprene (C5) building blocks; monoterpenes (menthol), sesquiterpenes, diterpenes (Vitamin A, retinal), tetraterpenes (carotenoids — β-carotene, lycopene), polyterpenes (rubber, dolichol)
Proteins
- Amino acids: 20 standard; α-amino acid — NH₂, COOH, H, R group on α-carbon; L-configuration; zwitterion at physiological pH
- Classification by R group: non-polar aliphatic (Gly, Ala, Val, Leu, Ile, Pro, Met); aromatic (Phe, Trp, Tyr); polar uncharged (Ser, Thr, Cys, Asn, Gln); positively charged at pH 7 (Lys, Arg, His); negatively charged at pH 7 (Asp, Glu)
- Peptide bond: condensation between α-COOH and α-NH₂; planar; partial double bond character → no free rotation; cis or trans (trans preferred — less steric clash)
- Protein structure levels: Primary (amino acid sequence — dictates all higher levels); Secondary (local regular folding — α-helix: 3.6 residues/turn, H-bond i to i+4; β-sheet: parallel or antiparallel H-bonding between extended strands; β-turns; Ω-loops); Tertiary (overall 3D folding — held by hydrophobic core, H-bonds, ionic bonds, disulfide bridges); Quaternary (multiple subunits; haemoglobin = α₂β₂)
- Ramachandran plot: allowed φ and ψ (backbone dihedral angles); right-handed α-helix and β-sheets are in allowed regions; proline and glycine have unique constraints
- Protein folding: hydrophobic collapse drives folding; chaperones (Hsp70, GroEL/GroES) assist and prevent aggregation; prions — misfolded proteins that template misfolding of native proteins (PrPᶜ → PrPˢᶜ)
Nucleic Acids
- Nucleotide = nitrogenous base + pentose sugar + 1–3 phosphates; nucleoside = base + sugar only
- Purines: Adenine (A) and Guanine (G) — double ring; Pyrimidines: Cytosine (C), Thymine (T in DNA), Uracil (U in RNA) — single ring
- DNA: B-form most common (Watson-Crick 1953); right-handed double helix; antiparallel strands (5'→3' and 3'→5'); A–T (2 H-bonds), G–C (3 H-bonds); major and minor grooves; A-form (RNA duplexes, short RNA–DNA), Z-form (left-handed; GC-rich; role in gene regulation)
- RNA: single-stranded; U instead of T; ribose; mRNA (protein-coding), tRNA (adaptor — anticodon loop; aminoacyl-tRNA synthetase charges tRNA), rRNA (ribosome — structural + catalytic; 23S rRNA is the ribozyme that forms peptide bonds), snRNA (splicing), miRNA/siRNA (gene silencing), lncRNA (chromatin regulation)
- Conformation of tRNA: L-shaped 3D structure; CCA-3' at 3' end (amino acid attachment); anticodon loop at opposite end
Vitamins and Coenzymes
| Vitamin | Coenzyme Form | Metabolic Role | Deficiency |
|---|---|---|---|
| B₁ (Thiamine) | TPP (Thiamine Pyrophosphate) | Oxidative decarboxylation (PDH, α-KG DH, transketolase) | Beri-beri; Wernicke-Korsakoff |
| B₂ (Riboflavin) | FMN, FAD | Electron carrier in ETC; β-oxidation; Complex I and II | Ariboflavinosis; angular cheilitis |
| B₃ (Niacin) | NAD⁺, NADP⁺ | 200+ oxidation-reduction reactions; NADP for anabolic reactions (pentose phosphate pathway, fatty acid synthesis) | Pellagra — 4Ds |
| B₅ (Pantothenic acid) | CoA (Coenzyme A) | Acetyl-CoA; fatty acid synthesis (ACP); TCA cycle entry | Rare; burning feet |
| B₆ (Pyridoxine) | PLP (Pyridoxal phosphate) | Transamination; decarboxylation; amino acid metabolism; glycogen phosphorylase | Peripheral neuropathy; sideroblastic anaemia |
| B₇ (Biotin) | Biotin-enzyme complex | Carboxylation: pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase | Alopecia; dermatitis |
| B₉ (Folate) | THF (Tetrahydrofolate) | One-carbon transfers; purine/pyrimidine synthesis; methionine cycle; neural tube development | Megaloblastic anaemia; NTD |
| B₁₂ (Cobalamin) | Methylcobalamin, Adenosylcobalamin | Methionine synthase (with THF); methylmalonyl-CoA mutase; myelin synthesis | Pernicious anaemia; Subacute Combined Degeneration |
| C (Ascorbate) | Acts directly (not coenzyme) | Prolyl/lysyl hydroxylase (collagen); antioxidant; iron absorption; epinephrine synthesis | Scurvy |
1.3 Stabilizing Interactions and Biophysical Chemistry
- pH and pKa: Henderson-Hasselbalch equation pH = pKa + log([A⁻]/[HA]); at pH = pKa, 50% ionised; physiological pH 7.4
- Buffers: resist pH change; bicarbonate buffer (blood — H₂CO₃/HCO₃⁻, pKa 6.1); phosphate buffer (intracellular — H₂PO₄⁻/HPO₄²⁻, pKa 6.8); protein buffer (histidine residues, pKa ~6)
- Thermodynamics: Gibbs free energy ΔG = ΔH – TΔS; spontaneous if ΔG < 0; equilibrium when ΔG = 0; ΔG° = –RT ln Keq; coupled reactions: exergonic (–ΔG) drives endergonic (+ΔG)
- ATP as energy currency: phosphoanhydride bonds (~7.3 kcal/mol each); ATP + H₂O → ADP + Pi (–7.3 kcal/mol); ATP → AMP + PPi (–7.3 kcal/mol); PPi → 2Pi drives irreversible reactions
- Colligative properties: depend on number of solute particles, not identity; osmotic pressure (πV = nRT); freezing point depression; boiling point elevation; relevant to osmosis across cell membranes
1.4 Bioenergetics and Metabolism Overview
- Glycolysis (Embden-Meyerhof-Parnas): glucose → 2 pyruvate; net yield 2 ATP + 2 NADH; key enzymes: Hexokinase (regulated by G-6-P), PFK-1 (rate-limiting; activated by AMP, F-2,6-BP; inhibited by ATP, citrate), Pyruvate kinase
- TCA cycle (Krebs cycle): Acetyl-CoA + OAA → citrate → (8 steps) → OAA; per turn: 3 NADH + 1 FADH₂ + 1 GTP + 2 CO₂; irreversible steps: isocitrate DH (rate-limiting), α-KG DH, citrate synthase
- Oxidative phosphorylation: NADH → Complex I → CoQ → Complex III → Cyt c → Complex IV → O₂ (½ → H₂O); FADH₂ → Complex II → CoQ; Proton gradient drives ATP synthase (Complex V); P/O ratio: NADH = 2.5 ATP, FADH₂ = 1.5 ATP
- Total ATP from glucose: ~30–32 ATP (2 glycolysis + 2 TCA + ~26–28 oxidative phosphorylation)
- Fatty acid β-oxidation: activation (acyl-CoA); transport across inner mitochondrial membrane (carnitine shuttle); spiral of 4 reactions (oxidation-hydration-oxidation-thiolysis); each 2C removed → 1 FADH₂ + 1 NADH + 1 acetyl-CoA; palmitate (16C) → 8 acetyl-CoA + 7 FADH₂ + 7 NADH → ~106 ATP
- Pentose phosphate pathway (PPP): G-6-P → ribose-5-P (for nucleotide synthesis) + NADPH (for reductive biosynthesis, antioxidant — regenerates glutathione); G6PD deficiency → haemolytic anaemia with oxidant drugs/fava beans
Allosteric regulation of glycolysis: PFK-1 is the main control point. ATP (high energy) inhibits PFK-1 (slows glycolysis when energy is sufficient). AMP/ADP (low energy) activates PFK-1 (speeds up glycolysis). Citrate (signals sufficient biosynthetic precursors) inhibits PFK-1. Fructose-2,6-bisphosphate (F-2,6-BP, made by PFK-2) powerfully activates PFK-1.
1.5 Enzymes and Enzyme Kinetics
- Enzymes: biological catalysts; lower activation energy (Ea); not consumed; highly specific; regulated
- Active site: small region that binds substrate and catalyses reaction; amino acid residues determine specificity (Lock and Key model — rigid; Induced Fit model — flexible, conformational change upon substrate binding — more accurate)
- Michaelis-Menten kinetics: v = Vmax[S]/(Km + [S]); Km = [S] at ½Vmax (affinity measure — lower Km = higher affinity); Vmax = maximum velocity; kcat = turnover number (reactions/enzyme/sec); kcat/Km = catalytic efficiency
- Lineweaver-Burk (double reciprocal plot): 1/v vs 1/[S]; y-intercept = 1/Vmax; x-intercept = –1/Km; used to determine inhibitor type
| Inhibitor Type | Binding | Effect on Km | Effect on Vmax | Lineweaver-Burk |
|---|---|---|---|---|
| Competitive | Active site (competes with substrate) | ↑ (apparent Km increases) | Unchanged | Same y-intercept; changed x-intercept (pivot at y-axis) |
| Uncompetitive | Only enzyme-substrate complex (ES) | ↓ (apparent Km decreases) | ↓ | Parallel lines (same slope) |
| Non-competitive (Mixed) | Enzyme or ES (allosteric site) | Unchanged (pure non-competitive) | ↓ | Same x-intercept; different y-intercept (pivot at x-axis) |
- Allosteric regulation: effector binds distal allosteric site → conformational change → alters activity; cooperative binding (sigmoidal kinetics — Hill equation); homotropic (substrate itself) vs heterotropic (different molecule) allosterism
- Covalent modification: phosphorylation (Ser, Thr, Tyr — by kinases; reversed by phosphatases); acetylation; ubiquitination; glycosylation; ADP-ribosylation
- Zymogen activation: inactive precursor activated by proteolytic cleavage; examples: trypsinogen → trypsin (by enterokinase); pepsinogen → pepsin (acid pH); blood clotting cascade; caspases (apoptosis)
- Enzyme classes (EC numbering): 1 Oxidoreductases, 2 Transferases, 3 Hydrolases, 4 Lyases, 5 Isomerases, 6 Ligases (synthetases)
- Ribozymes: catalytic RNA; 23S rRNA (peptidyl transferase activity in ribosome); self-splicing introns (Group I and II); RNase P (tRNA processing)
Km is NOT the same as affinity for all enzymes. For Michaelis-Menten enzymes (non-cooperative), Km ≈ Kd (dissociation constant) and lower Km = higher affinity. For allosteric enzymes with cooperative kinetics, Km cannot be directly interpreted as affinity. Know both cases for UPSC.
Unit 2 — Paper I
U2 Cellular Organization
2.1 Membrane Structure and Function
- Fluid Mosaic Model (Singer and Nicolson, 1972): lipid bilayer is fluid (lateral movement of lipids, "flip-flop" very rare); proteins embedded (integral) or attached (peripheral); cholesterol regulates fluidity
- Membrane lipid composition: phospholipids (majority); sphingolipids; cholesterol; glycolipids (outer leaflet only — sugar facing out); asymmetric distribution between leaflets
- Membrane proteins: Integral (transmembrane — single pass or multi-pass; glycophorin, ion channels, receptors, transporters); Peripheral (attached to surface by electrostatic/H-bonds; cytochrome c, spectrin)
- Membrane transport: Simple diffusion (small non-polar molecules — O₂, CO₂, N₂, steroid hormones; small uncharged polar — H₂O, glycerol); Facilitated diffusion (requires transporter or channel; glucose transporter GLUT, aquaporins, ion channels — no energy); Active transport (requires ATP; Primary — directly uses ATP, e.g., Na⁺/K⁺-ATPase; Secondary — uses ion gradient, e.g., Na⁺-glucose symport in intestine)
- Na⁺/K⁺-ATPase: 3 Na⁺ out, 2 K⁺ in per ATP; maintains resting membrane potential; inhibited by ouabain (cardiac glycoside)
- Osmosis: water moves across semipermeable membrane from low to high solute concentration (hypotonic → hypertonic); turgor pressure in plants; cell lysis in hypo-osmotic environment; crenation (animal cells) in hyper-osmotic environment
Membrane fluidity determinants: Temperature ↑ → fluidity ↑; Unsaturated FAs ↑ (cis double bonds create kinks) → fluidity ↑; Short chain FA ↑ → fluidity ↑; Cholesterol — complex role: below Tm raises fluidity; above Tm lowers fluidity (prevents solidification but also prevents excessive fluidity); acts as a "fluidity buffer."
2.2 Organelles — Structure and Function
Nucleus
- Bounded by nuclear envelope (double membrane); nuclear pore complexes (NPCs) — 120 nm diameter; RanGTP gradient controls import/export
- Nucleoplasm contains: chromatin (euchromatin — transcriptionally active; heterochromatin — condensed, silent); nucleolus (rRNA synthesis and ribosome assembly; 45S pre-rRNA → 28S + 18S + 5.8S); nuclear lamina (Lamin A, B, C — provides structural support; mutations → Hutchinson-Gilford Progeria)
Mitochondria
- Double membrane; cristae (inner membrane folds — increase surface area for ATP synthesis); matrix (TCA cycle enzymes, mtDNA, ribosomes)
- Outer membrane: porin channels (VDAC) — large molecule passage; Inner membrane: impermeable (maintains proton gradient); electron transport chain complexes (I–IV) + ATP synthase (Complex V)
- ATP synthase (F₀F₁-ATPase): F₀ embedded in inner membrane (proton channel); F₁ protrudes into matrix (catalytic head); proton flow through F₀ rotates γ-subunit → drives ATP synthesis
- Mitochondrial DNA (mtDNA): 16.5 kb circular; 37 genes (13 polypeptides of ETC/ATP synthase, 22 tRNAs, 2 rRNAs); maternal inheritance; D-loop region (control region for replication/transcription); mtDNA mutations → MERRF, MELAS, Leber's hereditary optic neuropathy
- Endosymbiotic origin: α-proteobacterial ancestor; supported by double membrane, circular DNA, 70S ribosomes, binary fission
Chloroplast
- Triple membrane (outer, inner, thylakoid); stroma (dark reactions — Calvin cycle); thylakoid membrane (light reactions — PS I and PS II, ETC, ATP synthase); grana (stacked thylakoids); stroma lamellae (unstacked, connecting grana)
- Photosystems: PS II (P680 — chlorophyll absorbs at 680 nm; water splitting — O₂ evolution; plastoquinone accepts electrons); PS I (P700; NADP⁺ reduction; final electron acceptor is NADPH)
- Z-scheme: H₂O → PS II → PQ → Cyt b₆f → PC → PS I → Fd → FNR → NADPH; ATP made by photophosphorylation (proton gradient from stroma→thylakoid lumen)
- Calvin cycle (dark/light-independent reactions): CO₂ + RuBP → 2 PGA (via RuBisCo); PGA → G3P (uses ATP + NADPH from light reactions); G3P → RuBP (regeneration — uses ATP); net: 3 CO₂ → 1 G3P (requires 9 ATP + 6 NADPH)
- Photorespiration: RuBisCo adds O₂ to RuBP → phosphoglycolate (wasteful); C4 plants (maize, sugarcane) suppress by CO₂ concentration in bundle sheath cells (Hatch-Slack pathway); CAM plants (cacti) fix CO₂ at night
Endoplasmic Reticulum and Golgi
- Rough ER (RER): studded with ribosomes; site of synthesis of secretory/membrane proteins; N-glycosylation begins; protein folding (Hsp70/BiP, calnexin, calreticulin); quality control → misfolded proteins degraded (ERAD)
- Smooth ER (SER): no ribosomes; lipid synthesis (phospholipids, cholesterol, steroid hormones); drug detoxification (CYP450 enzymes in liver SER); Ca²⁺ store (IP₃-mediated Ca²⁺ release)
- Golgi apparatus: cis (receives from ER) → medial → trans (sorts and ships); O-glycosylation; glycolipid synthesis; protein sorting — default pathway is secretion; lysosomal proteins tagged with mannose-6-phosphate (M6P); vesicular trafficking: COP-II (ER→Golgi anterograde), COP-I (Golgi→ER retrograde), Clathrin (trans-Golgi→endosome→lysosome; receptor-mediated endocytosis)
- Lysosomes: acid hydrolases (active at pH 5); formed by fusion of late endosomes + vesicles from Golgi; phagocytosis (bacteria, dead cells), autophagy (damaged organelles); lysosomal storage diseases: Tay-Sachs (β-hexosaminidase A deficiency → GM₂ ganglioside accumulation), Gaucher (glucocerebrosidase), Niemann-Pick (sphingomyelinase)
Cytoskeleton
| Component | Subunit | Diameter | Functions | Key Proteins |
|---|---|---|---|---|
| Microfilaments (Actin filaments) | Actin (G-actin → F-actin) | 7 nm | Cell shape; motility (lamellipodia, filopodia); muscle contraction; cytokinesis (contractile ring); endocytosis; microvilli | Myosin (motor); ARP2/3 (nucleation); Profilin (polymerisation); Cofilin (depolymerisation) |
| Intermediate filaments | Various (Keratin, Vimentin, Desmin, Lamins, Neurofilaments, GFAP) | 10 nm | Mechanical stability; structural support; nuclear lamina; cell-cell junctions (desmosomes) | Cell-type specific; no known motor proteins |
| Microtubules | α- and β-tubulin dimers (protofilaments → 13 PF hollow tube) | 25 nm | Chromosome segregation (mitotic spindle); cell polarity; vesicle transport (via kinesin +end; dynein –end); cilia and flagella (axoneme); MTOC (centrosome) | Kinesin (anterograde, +end directed); Dynein (retrograde, –end directed); MAP (microtubule-associated proteins) |
Treadmilling: in both actin and microtubules, monomers are added preferentially at one end (+end or barbed end) and removed from the other (–end or pointed end) — the filament appears to move while maintaining constant length. Dynamic instability (microtubules): rapid switch between growing and shrinking phases (GTP-cap model).
2.3 Cell Division — Mitosis and Meiosis
Mitosis
- Purpose: growth, repair, asexual reproduction; produces 2 genetically identical diploid daughter cells
- Prophase: chromatin condenses; nuclear envelope breaks down; spindle forms (from centrosomes in animals)
- Prometaphase: nuclear envelope gone; kinetochore microtubules attach to kinetochores; chromosomes begin moving
- Metaphase: chromosomes align at metaphase plate (plate is equidistant from poles); spindle assembly checkpoint (SAC) — ensures all kinetochores attached; Mad1, Mad2, BubR1 — delay anaphase until all chromosomes bi-oriented
- Anaphase: cohesins cleaved by separase (activated when SAC satisfied — securin degraded → separase active); sister chromatids pulled to poles; kinetochore microtubule shortening; polar microtubule elongation
- Telophase + Cytokinesis: nuclear envelopes reform; chromosomes decondense; cleavage furrow (animals — contractile ring of actin + myosin); cell plate (plants — vesicles fuse at equatorial plate)
Meiosis
- Purpose: sexual reproduction; produces 4 genetically distinct haploid daughter cells; two divisions (Meiosis I and II)
- Meiosis I (Reductional division): homologous chromosomes separate
- Prophase I substages: Leptotene (chromosomes condense), Zygotene (synapsis — homologs pair via synaptonemal complex), Pachytene (crossing over — chiasmata form; key stage for recombination), Diplotene (synaptonemal complex dissolves; chiasmata visible; lampbrush chromosomes in oocytes), Diakinesis (maximal condensation; terminalization of chiasmata)
- Metaphase I: bivalents (tetrads) align at plate; random assortment
- Anaphase I: homologs separate (cohesins cleaved except at centromere region — protected by Shugoshin/PP2A); sister chromatids remain joined
- Meiosis II: similar to mitosis; separates sister chromatids
- Significance of meiosis: Genetic diversity via crossing over (recombination) and independent assortment; halving of chromosome number (restored at fertilisation)
Cell Cycle and its Regulation
- Phases: G₁ (growth, preparation) → S (DNA synthesis) → G₂ (growth, check) → M (mitosis) → (G₀ — quiescence)
- Cyclins and CDKs: Cyclin D/CDK4,6 (G₁ — phosphorylate Rb); Cyclin E/CDK2 (G₁/S transition); Cyclin A/CDK2 (S phase); Cyclin A,B/CDK1 (G₂/M — MPF: M-phase Promoting Factor)
- Rb protein: tumour suppressor; unphosphorylated Rb binds E2F (transcription factor) → inhibits S-phase genes; CDK4/6-Cyclin D phosphorylates Rb → E2F released → transcribes genes for S phase entry
- Checkpoints: G₁/S checkpoint (DNA damage? → p53 → p21 → CDK inhibition → arrest); G₂/M checkpoint (DNA replicated?); Spindle Assembly Checkpoint (all chromosomes attached?)
- p53 — guardian of the genome: tumour suppressor; activated by DNA damage; induces p21 (CDK inhibitor → G₁ arrest), promotes DNA repair, induces apoptosis if damage irreparable; mutated in ~50% of all cancers
2.4 Chromosome Structure and Types
- Nucleosome: 147 bp DNA wound 1.7 turns around histone octamer (H2A, H2B, H3, H4 — two each); linked by 10–80 bp linker DNA + H1; "beads on a string" (10 nm fibre) → 30 nm fibre → 300 nm loops → 700 nm → 1400 nm (metaphase chromosome)
- Histone modifications: Acetylation (by HAT; removes positive charge; loosens DNA-histone → active transcription); Deacetylation (by HDAC → repression); Methylation (H3K4me3 — active; H3K9me3 — repression; H3K27me3 — Polycomb repression); Phosphorylation (H3S10-P — mitosis); Ubiquitination (H2A — repression; H2B — transcription)
- Polytene chromosomes: endoreduplication (DNA replication without cell division); homologs paired; 1000+ copies; puffs = actively transcribed regions; seen in Drosophila salivary glands; used for chromosome mapping
- Lampbrush chromosomes: diplotene stage of meiosis I in oocytes (amphibians especially); lateral loops extend from chromomeres; actively transcribing; can be visualised under light microscope
- B chromosomes: supernumerary chromosomes; not essential; found in many species; may confer some reproductive advantage
Unit 3 — Paper I
U3 Fundamental Processes — DNA Replication, Transcription, Translation
3.1 DNA Replication
- Semiconservative: each daughter DNA has one old and one new strand (Meselson-Stahl experiment 1958 — ¹⁵N/¹⁴N density gradient centrifugation)
- Origin of replication (ori): prokaryotes — single oriC; eukaryotes — multiple origins (ARS in yeast); initiator proteins bind ori → recruit helicase
- Eukaryotic replication machinery:
Helicase (MCM complex)Unwinds double helix at replication fork; uses ATP; loaded onto ori before S phase (licensed by CDT1, CDC6)
SSB (RPA in eukaryotes)Single-strand DNA binding proteins; stabilise unwound strands; prevent re-annealing and hairpin formation
Topoisomerase I and IIRelax supercoiling ahead of replication fork; Type I — one nick, rotate, re-ligate; Type II — double-strand break (target for camptothecin, etoposide anticancer drugs)
PrimaseSynthesises RNA primers (8–12 nucleotides) on both strands; provides free 3'-OH for DNA pol to extend
DNA Pol δ (lagging) and ε (leading)Main replicative polymerases; 5'→3' synthesis only; 3'→5' exonuclease proofreading; require primer
DNA Pol α (Pol-primase complex)Initiates each Okazaki fragment with primer + ~20 nt DNA; then hands off to Pol δ
PCNA (sliding clamp)Processivity factor for Pol δ; keeps polymerase on DNA; loaded by RFC (clamp loader)
RNase H1 + FEN1Remove RNA primers (RNase H1 degrades RNA of RNA:DNA hybrid; FEN1 cleaves flap); gaps filled by Pol δ
DNA Ligase ISeals nicks between Okazaki fragments (requires NAD⁺ in prokaryotes, ATP in eukaryotes)
- Okazaki fragments: lagging strand synthesised discontinuously in 100–200 bp (eukaryotes) or 1000–2000 bp (prokaryotes) fragments; each needs new primer
- Telomere replication: conventional DNA pol cannot replicate 5' ends (end-replication problem → chromosome shortening); Telomerase (a ribonucleoprotein — telomerase RNA component TERC + TERT reverse transcriptase) extends 3' end; active in germ cells, stem cells, cancer cells; absent/inactive in most somatic cells → replicative senescence
Telomere shortening theory of ageing: each cell division loses 50–200 bp of telomeric repeats (TTAGGG)n. After ~50 divisions (Hayflick limit), telomeres critically short → DNA damage response → senescence. Cancer cells reactivate telomerase → immortal. Drugs targeting telomerase are being developed as anticancer agents.
DNA Damage and Repair
| Damage Type | Cause | Repair Mechanism | Enzymes |
|---|---|---|---|
| Depurination/Depyrimidination | Spontaneous hydrolysis; alkylating agents | Base Excision Repair (BER) | DNA glycosylase (removes damaged base) → AP endonuclease → pol β → ligase |
| UV-induced pyrimidine dimers (CPD, 6-4PP) | UV-B radiation; thymine dimers (TT most common) | Nucleotide Excision Repair (NER); Photoreactivation (lower organisms) | XPC-RAD23B (recognise); TFIIH (unwinds); XPG + XPF/ERCC1 (cut ~25–30 nt fragment); Pol δ/ε + Ligase; XP (Xeroderma Pigmentosum) — NER defect |
| Mismatches (after replication errors) | DNA pol error; oxidative damage | Mismatch Repair (MMR) | MutS (recognise mismatch) + MutL + MutH (nick old strand); exonuclease removes; re-synthesis; Lynch syndrome — MMR defect |
| Double-strand breaks (DSBs) | Ionising radiation; chemotherapy (bleomycin, topoisomerase inhibitors); replication fork collapse | Homologous Recombination (HR — error-free, in S/G₂); Non-Homologous End Joining (NHEJ — error-prone, any phase) | HR: RAD51 (strand invasion), BRCA1, BRCA2; NHEJ: Ku70/Ku80, DNA-PKcs, LIG4 |
| Alkylation (O⁶-methylguanine) | Alkylating agents (EMS, nitrosoguanidine); tobacco smoke | Direct repair (reversal) | O⁶-methylguanine DNA methyltransferase (MGMT) — suicide enzyme (accepts methyl group onto itself) |
3.2 Transcription
- RNA synthesis: 5'→3' direction; template (antisense) strand read 3'→5'; no primer needed; uses NTPs (ribo-); one-strand of DNA used as template
- Prokaryotic transcription: single RNA pol (core: α₂ββ'ω; holoenzyme with σ factor); σ recognises –10 and –35 promoter elements (consensus: TATAAT at –10, TTGACA at –35); different σ factors for different conditions (σ⁷⁰ — housekeeping, σ³² — heat shock); termination: Rho-independent (hairpin loop + U-run) or Rho-dependent (ATP-dependent RNA helicase Rho)
- Eukaryotic transcription: three RNA polymerases (Pol I — rRNA 45S; Pol II — mRNA + most snRNA + miRNA; Pol III — tRNA, 5S rRNA, snRNA); Pol II requires general transcription factors (TFIID-TATA box binding, TFIIA, TFIIB, TFIIF, TFIIE, TFIIH — helicase + CTD kinase); Mediator complex connects activators to Pol II
mRNA Processing (Eukaryotes)
- 5' capping: 7-methylguanosine cap added co-transcriptionally; protects from exonuclease degradation; required for ribosome recognition and translation initiation
- 3' polyadenylation: cleavage after AAUAAA polyadenylation signal; poly(A) polymerase adds 200–250 A residues; stability; mRNA export
- Splicing: removal of introns; spliceosome (snRNPs: U1, U2, U4, U5, U6 snRNAs + proteins); two transesterification steps; branch point A in intron; lariat intermediate; alternative splicing → multiple protein isoforms from one gene (human: ~95% of multi-exon genes undergo AS)
- Alternative splicing types: Exon skipping (most common in vertebrates); Alternative 5' splice site; Alternative 3' splice site; Intron retention; Mutually exclusive exons
- RNA editing: A-to-I editing by ADAR (adenosine deaminase acting on RNA); C-to-U editing by APOBEC; changes codon identity; ApoB-100 → ApoB-48 by C-to-U editing in intestine
Gene Regulation
- Prokaryotic gene regulation: Operon model (Jacob and Monod, 1961); lac operon (inducible — glucose absent + lactose present → CAP-cAMP activates, repressor off); trp operon (repressible — tryptophan present → activates repressor → turns off); attenuation (trp operon — ribosome stalling at leader peptide)
- Eukaryotic cis-regulatory elements: Promoter (core: TATA box ~–25; Inr; DPE); Enhancers (can be far, looping); Silencers; Insulators (CTCF — boundary elements)
- Transcription factors: DNA-binding domains (Zinc finger, Leucine zipper/bZIP, Helix-turn-helix, Helix-loop-helix); activation domains (acidic, proline-rich, glutamine-rich)
- Chromatin remodelling: SWI/SNF complex (uses ATP to reposition nucleosomes); histone modifying enzymes (HATs, HDACs, HMTs, HDMs) → change accessibility to transcription machinery
- Epigenetic regulation: DNA methylation (5-methylcytosine at CpG islands — gene silencing; maintained by DNMT1 after replication; de novo methylation by DNMT3A/3B); histone modifications; non-coding RNAs
- RNA interference (RNAi): miRNA (encoded by genome; ~22 nt; processed by Drosha/DGCR8 in nucleus → Dicer in cytoplasm → RISC complex; partial complementarity → mRNA degradation or translational repression); siRNA (exogenous dsRNA; perfect complementarity → mRNA cleavage by Argonaute); piRNA (germ cell transposon silencing)
3.3 Translation
- Genetic code: 64 codons for 20 amino acids + 3 stop codons (UAA, UAG, UGA); degenerate/redundant (multiple codons per AA; wobble at 3rd position — Crick 1966); universal (few exceptions — mitochondria, Mycoplasma); non-overlapping; unambiguous (each codon = one AA)
- Start codon: AUG (Met in eukaryotes; fMet in prokaryotes); Kozak sequence context in eukaryotes (GCCRCCAUGG, R = purine)
- tRNA: adaptor molecule; anticodon on anticodon loop; amino acid attached to CCA-3' by aminoacyl-tRNA synthetase (20 enzymes — one per AA; uses ATP; proofreading activity); wobble — non-standard base pairing at 3rd codon position (inosine most flexible)
Translation Steps
Initiation (eukaryote)eIF2-GTP-Met-tRNA + 40S ribosome → 43S pre-initiation complex; cap-binding (eIF4E + eIF4G + eIF4A) → mRNA scanning for AUG; 60S joins (eIF5-GTP hydrolysis) → 80S; IRES (internal ribosome entry site) — cap-independent
ElongationA (aminoacyl), P (peptidyl), E (exit) sites; EF-Tu-GTP brings aa-tRNA to A site; peptidyl transferase (23S rRNA ribozyme) forms peptide bond; EF-G-GTP-mediated translocation (A→P→E); proofreading by EF-Tu's GTPase (delay for correct codon)
TerminationStop codon (UAA/UAG/UGA) in A site; release factors (eRF1 recognises all 3 stop codons; eRF3-GTP); hydrolysis of peptidyl-tRNA → polypeptide released; ribosome recycling factors dissociate
- Polysome (polyribosome): multiple ribosomes translating same mRNA simultaneously — increases efficiency
- Protein targeting: Signal Hypothesis (Blobel and Sabatini); signal peptide (N-terminal hydrophobic); SRP (Signal Recognition Particle) recognises signal → docks with SRP receptor on RER → co-translational insertion into ER
- Post-translational modifications: signal peptide cleavage; glycosylation; phosphorylation; acetylation; ubiquitination (26S proteasome degradation); prenylation; GPI anchoring; disulfide bond formation (in ER lumen — PDI catalyses)
- Protein folding and chaperones: Hsp70 (BiP in ER) — binds hydrophobic segments of unfolded proteins; GroEL/GroES (Hsp60) — barrel-shaped cage for folding; Hsp90 — client proteins include steroid hormone receptors, kinases
- UPR (Unfolded Protein Response): triggered by ER stress (accumulation of misfolded proteins); sensors: IRE1, PERK, ATF6 → reduce translation + increase chaperone production; if unresolved → apoptosis
Nonsense-mediated decay (NMD): surveillance mechanism; degrades mRNAs with premature stop codons (PTCs); prevents production of truncated, potentially dominant-negative proteins. Coupled to splicing — exon junction complexes (EJCs) deposited at exon junctions; if ribosome encounters EJC downstream of stop codon → NMD triggered.
3.4 DNA Topology and the Modern Concept of the Gene
- DNA topology: supercoiling (over/under-winding); negative supercoiling (underwound — in bacteria and eukaryotic chromatin) facilitates strand separation for replication and transcription; positive supercoiling ahead of replication fork; topoisomerases resolve
- DNA motifs: TATA box, CAAT box, GC box, E-box, CpG islands (often near promoters — hypomethylated in active genes)
- Modern gene concept: gene = DNA sequence specifying functional product (RNA or protein); includes regulatory sequences, introns, UTRs; one gene can produce multiple products via alternative splicing, alternative promoters, alternative polyadenylation, RNA editing
- Split genes (interrupted genes): discovered by Roberts and Sharp (1977 Nobel 1993); introns interrupt coding sequences; mosaic genes; exon shuffling in evolution
- Pseudogenes: non-functional gene copies; processed pseudogenes (retrotransposed cDNA copies); duplicated pseudogenes (lost function by mutation)
- Non-coding RNA genes: miRNA, siRNA, lncRNA, piRNA, circRNA — transcribed but not translated; regulatory functions; much of "junk DNA" is transcribed into ncRNA
Unit 4 — Paper I
U4 Cell Communication and Cell Signaling
4.1 Principles of Cell Signaling
- Types of signaling: Endocrine (hormones via blood — long range); Paracrine (local diffusion — cytokines, growth factors); Autocrine (cell responds to own signals — common in cancer); Juxtacrine (contact-dependent — Notch-Delta, EGF ligand)
- Signal transduction steps: Ligand binding → receptor activation → transduction (second messengers, kinase cascades) → effector response → signal termination
- Second messengers: cAMP (adenylyl cyclase → PDE degrades); cGMP; IP₃ (releases Ca²⁺ from ER); DAG (activates PKC); Ca²⁺ (binds calmodulin → CaM kinase II, MLCK); nitric oxide (NO — activates soluble guanylyl cyclase)
Receptor Classes
| Receptor Type | Examples | Mechanism | Signaling |
|---|---|---|---|
| G Protein-Coupled Receptors (GPCRs) | β-adrenergic receptor (adrenaline), Rhodopsin (vision), Muscarinic AChR, Olfactory receptors, Glucagon receptor | 7-transmembrane α-helices; ligand binding → GDP→GTP on Gα; Gα-GTP dissociates → activates effector; intrinsic GTPase → Gα-GDP → re-associates with Gβγ | Gs: ↑ adenylyl cyclase → ↑ cAMP → PKA; Gi: ↓ adenylyl cyclase; Gq: activates PLCβ → IP₃ + DAG |
| Receptor Tyrosine Kinases (RTKs) | EGF receptor, Insulin receptor, PDGF-R, FGFR, VEGFR, IGF-1R | Ligand binding → receptor dimerisation → trans-autophosphorylation of tyrosine residues → docking sites for SH2-domain proteins | Ras/MAPK cascade (cell growth, proliferation); PI3K/Akt (survival, growth); PLCγ → IP₃ + DAG; JAK/STAT pathway |
| Nuclear Receptors | Steroid hormone receptors (ER, AR, GR, PR, MR); Thyroid hormone receptor; Retinoic acid receptor; Vitamin D receptor | Ligand (lipophilic) diffuses into cell → binds receptor in cytoplasm or nucleus → receptor-ligand complex acts as TF → binds HRE (hormone response element) in DNA | Direct gene transcription regulation; slow but sustained response; zinc finger DNA binding domain |
| Ion Channel-Linked Receptors (Ionotropic) | Nicotinic AChR (Na⁺/K⁺); NMDA receptor (Ca²⁺, voltage-gated); GABA-A receptor (Cl⁻); Glycine receptor (Cl⁻) | Ligand binding → direct opening of ion channel; conformational change; very fast (milliseconds) | Fastest signaling; neural transmission; membrane potential changes |
| Cytokine Receptors (JAK-STAT) | Interferon receptors, IL-2, IL-6, Erythropoietin, Growth hormone receptor | No intrinsic kinase; associated with JAK (Janus kinase) in cytoplasm; ligand binding → JAK trans-phosphorylation → phospho-STAT → dimerises → nucleus | Immune responses; cell differentiation; hematopoiesis |
| TGF-β Receptors (Serine-Threonine kinase) | TGF-β receptors I and II; BMP receptors; Activin receptors | TGF-β binds Type II receptor → phosphorylates Type I receptor → SMAD phosphorylation → SMAD complex → nucleus | Growth inhibition; EMT; fibrosis; dorsal-ventral patterning (BMP gradient) |
4.2 Key Signaling Pathways
Ras/MAPK Pathway
- RTK activation → Grb2-SOS complex recruited → SOS (GEF) activates Ras (GDP→GTP) → Ras-GTP → Raf (MAPKKK) → MEK (MAPKK) → ERK (MAPK) → transcription factors (Elk-1, Fos, c-Myc) → cell proliferation
- Ras is a GTPase — intrinsic GTPase activity terminates signaling (GAP proteins accelerate GTP hydrolysis); Ras mutations (G12V or Q61L) — oncogenic (constitutively active); mutated in ~30% cancers (K-Ras most common)
PI3K/Akt/mTOR Pathway
- RTK → PI3K phosphorylates PIP₂ → PIP₃ → recruits PDK1 and Akt (PKB) → Akt phosphorylates: mTOR (protein synthesis, cell growth), FOXO (survival), BAD (anti-apoptosis), GSK3β (glycogen synthesis), MDM2 (p53 degradation)
- PTEN (tumour suppressor): lipid phosphatase → dephosphorylates PIP₃ back to PIP₂ → negative regulator; mutated in many cancers (Cowden syndrome)
- mTOR: master growth regulator; mTORC1 (rapamycin-sensitive) → phosphorylates S6K and 4E-BP1 → protein synthesis, ribosome biogenesis, autophagy inhibition
Wnt/β-catenin Pathway
- Without Wnt: destruction complex (APC + Axin + GSK3β + CK1) phosphorylates β-catenin → ubiquitination → proteasomal degradation; TCF/LEF represses Wnt target genes
- With Wnt: Frizzled + LRP5/6 → Dishevelled → inhibits destruction complex → β-catenin accumulates → translocates to nucleus → TCF/LEF-β-catenin activates target genes (c-Myc, Cyclin D1, MMP-7) → cell proliferation
- APC mutation: most common in colorectal cancer (FAP — Familial Adenomatous Polyposis); loss of APC → uncontrolled β-catenin → unregulated proliferation
Notch Signaling
- Juxtacrine signaling; Notch receptor (transmembrane) on receiving cell; Delta/Jagged ligand on signaling cell
- Ligand binding → γ-secretase cleavage → Notch intracellular domain (NICD) released → enters nucleus → CSL transcription factor complex → Hes/Hey target genes → cell fate decisions (binary — neurogenesis, somitogenesis, lateral inhibition)
Signal Termination and Desensitisation
- Receptor phosphorylation by GRK (GPCR Kinase) → β-arrestin recruitment → receptor internalisation (clathrin-mediated) → receptor recycling or degradation
- Phosphodiesterase (PDE): degrades cAMP and cGMP; inhibited by caffeine (mild PDE inhibitor — explains mood effects)
- Phosphatases: protein phosphatases (PP1, PP2A, PP2B/calcineurin — target of cyclosporin in immunosuppression; PP2C); tyrosine phosphatases (PTP1B — insulin resistance target)
Cell death signaling: Intrinsic apoptosis pathway — DNA damage/stress → Bax/Bak (pro-apoptotic) → cytochrome c release → Apaf-1 + cytochrome c + caspase-9 → apoptosome → caspase-3 (executioner) → cell death; Bcl-2/Bcl-xL (anti-apoptotic) inhibit Bax/Bak → overexpressed in cancer → survival. Extrinsic pathway: FasL/TRAIL → death receptor (Fas/DR5) → FADD → caspase-8 → caspase-3.
Unit 5 — Paper I
U5 Developmental Biology
5.1 Embryogenesis and Early Development
- Fertilisation: sperm binds ZP3 on zona pellucida → acrosome reaction → penetration → sperm-egg membrane fusion → fast block to polyspermy (membrane depolarisation); slow block (cortical reaction — cortical granules fuse with egg membrane → zona reaction → permanent block); egg activation → meiosis II completion
- Cleavage: rapid mitotic divisions with no growth; maintains cytoplasm:nucleus ratio; holoblastic (entire egg cleaves — sea urchin, frog, mammal); meroblastic (partial — yolk-rich eggs; discoidal in fish, rotational in birds)
- Morula → Blastocyst (mammal): ICM (inner cell mass — gives embryo) + trophectoderm (gives placenta); implantation; OCT4, SOX2, NANOG — pluripotency factors in ICM
Establishment of Body Axes
- Drosophila body axes: A-P axis — Bicoid mRNA (anterior pole → Bicoid protein gradient → activates anterior gap genes like hunchback; inhibits posterior); Nanos mRNA (posterior → represses bicoid-type translation); D-V axis — Toll receptor gradient; terminal — Torso RTK
- Vertebrate A-P axis: Organiser (Spemann's organiser in amphibians — transplant → induces secondary axis; Hensen's node in chick; node in mouse); secretes inhibitors of BMP (Chordin, Noggin, Follistatin) → dorsal fate; BMP gradient → ventral fate; D-V axis established by BMP gradient
- Homeotic genes (Hox genes): define segment identity along A-P axis; discovered in Drosophila (homeotic mutations — antennapedia, bithorax); co-linearity — Hox genes expressed in same order along chromosome as their A-P expression domain; extremely conserved from Drosophila to humans; 39 Hox genes in humans (4 clusters: HOXA-D)
- Morphogens: signaling molecules that form concentration gradients → different cell fates at different concentrations; Bicoid, Activin/Nodal, Sonic Hedgehog (SHH), BMP, Wnt, Retinoic acid
Gastrulation
- Blastula → gastrula; establishment of three germ layers
- Frog gastrulation: dorsal blastopore lip (future notochord/Spemann organiser) involutes; bottle cells; three germ layers form
- Chick gastrulation: epiblast cells migrate through primitive streak → ingress; hypoblast → endoderm; epiblast → ectoderm and mesoderm after ingression; Hensen's node at anterior end of primitive streak = chick organiser
Fate Map and Cell Lineage
- Fate map: mapping regions of blastula/gastrula to their adult derivatives; using dye injection or lineage tracing (Cre-lox); Vogt developed vital dye technique
- Germ layers and derivatives: Ectoderm → epidermis, nervous system (neural induction — notochord secretes signals), sense organs, neural crest; Mesoderm → muscles, bones, blood, kidneys, gonads, heart; Endoderm → gut, liver, pancreas, lungs, thyroid
- Neural crest: "4th germ layer"; migratory cells from dorsal neural tube; forms: peripheral nervous system, craniofacial cartilage/bone, melanocytes, adrenal medulla (chromaffin cells), cardiac outflow tract; EMT (epithelial-to-mesenchymal transition) allows migration
5.2 Organogenesis — Eye and Heart Development
Eye Development
- Optic vesicle (from diencephalon) induces overlying ectoderm → lens placode → lens vesicle; optic vesicle invaginates → optic cup (bilayered: inner = neural retina, outer = RPE)
- Pax6 (Master control gene for eye): loss → no eye (eyeless in Drosophila); Pax6 overexpression anywhere → ectopic eye; highly conserved; induces entire eye developmental programme
- Retina specification: RGCs (retinal ganglion cells — only neurons that project axons to brain); rods (scotopic — dim light, rhodopsin); cones (colour, bright light — L/M/S cones); Müller glia; bipolar cells; amacrine; horizontal
Heart Development
- First organ to function in embryo; cardiomyocytes from lateral plate mesoderm (cardiac progenitor cells — FHF and SHF); heart tube forms and loops (rightward — D-looping); cardiac jelly; cardiac neural crest (great vessel formation)
- Key TFs: Nkx2.5 (homologue of tinman in Drosophila — required for heart formation), GATA4, Hand1/2, MEF2C, T-box factors (Tbx5 — mutations → Holt-Oram syndrome; Tbx20)
- Common congenital heart defects: VSD (ventricular septal defect — most common), ASD, tetralogy of Fallot, transposition of great arteries, patent ductus arteriosus
5.3 Developmental Genetics and Regeneration
- Genetic vs induced teratogenesis: Genetic — chromosomal anomalies (Down, Turner, Klinefelter), single gene mutations; Induced — teratogens (thalidomide — phocomelia via Wnt/CRBN; valproate — NTDs; isotretinoin — retinoic acid excess → craniofacial); radiation; infection (rubella → cardiac defects, deafness, cataracts)
- Thyroxine and metamorphosis in amphibia: thyroid hormone (T₃/T₄) drives metamorphosis in frogs; tail resorption (apoptosis), limb growth, lung development, gut remodelling; each tissue responds differently to same hormone (different receptor isoforms, local factors); hypothyroidism → arrested metamorphosis (neoteny in axolotl)
- Paedogenesis: sexual reproduction in larval stage (e.g., some insects); Neoteny: retention of juvenile features in adult; axolotl (Ambystoma mexicanum) — neotenic salamander; fails to metamorphose due to low thyroid sensitivity; can be induced by T₄
- Regeneration: replace lost body parts; Epimorphosis (de-differentiation then re-differentiation — Planaria, newt limb); Morphallaxis (remodelling without cell division — Hydra); Compensatory growth (liver regeneration — remaining hepatocytes divide); Stem cell-mediated (replacement from resident stem cells)
- Newt lens regeneration: only vertebrate that can regenerate lens; from pigmented epithelial cells of dorsal iris (transdifferentiation — mature differentiated cells convert to another type); Wnt, FGF, retinoic acid pathways
- Cell death (apoptosis in development): Apoptosis sculpts morphology; interdigital spaces (webbing removal); matching neuron numbers to targets (neurotrophic hypothesis — NGF withdrawal → apoptosis); thymus T cell selection; deletion of autoreactive lymphocytes
- Ageing: Telomere shortening; accumulation of ROS; mitochondrial dysfunction; senescent cells (SASP — senescence-associated secretory phenotype — chronic inflammation); epigenetic drift; NAD⁺ depletion; stem cell exhaustion; proteostasis failure
In Vitro Fertilisation and Embryo Transfer
- IVF: ovarian stimulation → oocyte retrieval → fertilisation in vitro → embryo culture → transfer to uterus; India: first test tube baby Durga (1978 Calcutta) and UK Louise Brown (1978, Robert Edwards — Nobel 2010)
- ICSI (Intracytoplasmic Sperm Injection): single sperm injected into egg; for severe male infertility
- PGD (Preimplantation Genetic Diagnosis): biopsy of 1–2 blastomeres from Day 3 embryo (8-cell); genetic testing before transfer; screens for chromosomal/single gene disorders
- Embryo cryopreservation: vitrification (rapid freezing) used now; long-term storage; donor egg programmes
Cloning and Stem Cells
- Somatic Cell Nuclear Transfer (SCNT): nucleus from somatic cell → enucleated oocyte → reprogramming by oocyte cytoplasm → cloned embryo; Dolly the sheep (Wilmut, 1996 — first cloned mammal from adult somatic cell); very inefficient (~1% success rate)
- iPSCs (Induced Pluripotent Stem Cells): Yamanaka (2006 Nobel 2012 with Gurdon); fibroblasts + 4 factors (Oct4, Sox2, Klf4, c-Myc or Oct4, Sox2, Lin28, Nanog) → reprogrammed to pluripotent stem cells; avoids ethical issues of ESC
- Stem cell types: Totipotent (zygote — can form all embryonic and extraembryonic tissues); Pluripotent (ICM, ESC, iPSC — all 3 germ layers but not placenta); Multipotent (HSC, MSC, NSC — limited lineages); Unipotent (satellite cells in muscle)
- Therapeutic uses of stem cells: Bone marrow transplant (HSC); skin grafting (epidermal stem cells); corneal transplant; clinical trials for Parkinson's, diabetes (β-cell replacement), spinal cord injury, ALS
Biogenetic Law (Ernst Haeckel, 1866): "Ontogeny recapitulates phylogeny" — the embryo passes through stages resembling embryos of ancestral forms. Modified view: embryos of related species are similar at early stages (phylotypic stage) but diverge later; gill slits in human embryos are reminiscent of fish ancestors but are not functional gills. Not strictly true but has heuristic value.
Unit 6 — Paper I
U6 System Physiology — Plant
6.1 Photosynthesis — Light and Dark Reactions
- Photosynthesis: 6CO₂ + 6H₂O + light → C₆H₁₂O₆ + 6O₂; two stages: light-dependent (thylakoid) + light-independent/Calvin cycle (stroma)
- Light reactions: Photon absorption by antenna pigments → funnelled to reaction centre chlorophyll; PS II (P680) — excited by light → oxidises water (Mn cluster — OEC, oxygen evolving complex → O₂); electrons → PQ → Cyt b₆f (pumps H⁺ → lumen) → PC → PS I (P700) → ferredoxin (Fd) → FNR → NADPH
- Cyclic photophosphorylation: PS I → Fd → Cyt b₆f → PC → PS I; produces only ATP (no NADPH, no O₂); used when NADPH/ATP ratio is high
- Photophosphorylation: ATP synthesis driven by proton gradient (lumen to stroma) through ATP synthase (CF₀CF₁); ~3 H⁺ per ATP
- Calvin cycle (C3 pathway): CO₂ + RuBP → 2 PGA (3C) via RuBisCO; PGA → G3P (3 ATP + 2 NADPH per CO₂ fixed for 6 turns to make 1 G3P net); regeneration of RuBP (9 ATP for 3 CO₂ fixed)
C4 and CAM Plants
| Feature | C3 Plants | C4 Plants | CAM Plants |
|---|---|---|---|
| First product of CO₂ fixation | 3-phosphoglycerate (3C) | Oxaloacetate (4C) | OAA at night; releases CO₂ to Calvin cycle during day |
| Primary carboxylating enzyme | RuBisCO | PEP carboxylase (mesophyll); then RuBisCO (bundle sheath) | PEP carboxylase (night); RuBisCO (day) |
| Photorespiration | High (RuBisCO oxygenase activity) | Negligible (CO₂ concentrated in bundle sheath) | Negligible |
| Leaf anatomy | Spongy mesophyll dominant; no Kranz anatomy | Kranz anatomy (ring of bundle sheath cells with many chloroplasts) | Succulent; large vacuoles; open stomata at night |
| Water use efficiency | Low | Moderate | Highest |
| Examples | Wheat, rice, potato, most trees | Maize (corn), sugarcane, sorghum, Amaranthus | Cacti, Agave, pineapple, orchids |
RuBisCO (Ribulose-1,5-bisphosphate carboxylase/oxygenase) is the most abundant protein on Earth (~700 million tonnes) but is a very slow enzyme (~3 CO₂/sec vs typical enzyme 1000/sec). Compensated by extremely high concentration in leaf. RuBisCO's oxygenase activity (photorespiration) is wasteful — improving RuBisCO is a major goal of agricultural biotechnology.
6.2 Plant Hormones
| Hormone | Site of Synthesis | Physiological Effects | Mechanism |
|---|---|---|---|
| Auxin (IAA) | Shoot apical meristem; young leaves; seeds | Cell elongation; apical dominance (inhibits lateral buds); phototropism (unequal distribution); gravitropism; root initiation; fruit development; adventitious roots | Activates proton pump (H⁺-ATPase) → acidifies cell wall → wall loosening (acid growth hypothesis) → turgor-driven expansion; auxin-responsive genes (ARF transcription factors) |
| Gibberellins (GA) | Young leaves, seeds, root tips | Stem elongation (bolting); seed germination; fruit development (seedless); flowering (long-day plants); enzyme synthesis (α-amylase in aleurone); breaks bud dormancy | GA receptor (GID1) + DELLA protein (repressor); GA-GID1-DELLA → DELLA ubiquitinated → proteasomal degradation → growth genes expressed |
| Cytokinins (CK) | Root apical meristem; developing seeds | Cell division (promotes cytokinesis); delay senescence (stays green); apical dominance (lateral bud release — opposite to auxin); shoot morphogenesis; chloroplast maturation | Receptors (AHK1-3 histidine kinases) → signaling cascade → ARR transcription factors |
| Abscisic acid (ABA) | Leaves (water-stressed); seeds; roots | Stomatal closure (drought response); seed dormancy; inhibits germination; leaf senescence; cold acclimation; promotes abscission (misleading name — role in abscission limited) | PYR/RCAR receptor → inhibits PP2C → SnRK2 kinase active → ion channels → guard cell K⁺ efflux, Cl⁻ efflux → turgor loss → stomata close |
| Ethylene (C₂H₄) | Almost all plant tissues; ripening fruit; stressed tissue | Fruit ripening; leaf/flower senescence; triple response in etiolated seedlings (inhibit elongation, thicken stem, horizontal growth); aerenchyma formation (flooding); promotes abscission; female sex determination in cucurbits | ACC synthase (rate-limiting) → ACC → ACC oxidase → ethylene; ethylene receptor (ETR1) — negative regulation; CTR1 kinase; EIN3/EIL1 TFs |
| Brassinosteroids (BR) | Pollen, immature seeds, young shoots | Cell elongation and division; photomorphogenesis suppression (skotomorphogenesis); vascular differentiation; pollen tube elongation; stress tolerance | BRI1 receptor kinase → SERK co-receptor → BIN2 kinase inactivation → BES1/BZR1 transcription factors active |
| Strigolactones (SL) | Roots | Inhibit lateral bud outgrowth (act with ABA against cytokinin); stimulate hyphal branching of mycorrhizal fungi; host recognition by parasitic plants (Striga) | Derived from carotenoids; D14 receptor; MAX/D proteins; relatively newly discovered (2008) |
6.3 Plant Nutrition and Transport
Mineral Nutrition
- Essential mineral elements: macro (N, P, K, Ca, Mg, S — required in large amounts); micro/trace (Fe, Mn, Zn, Cu, B, Mo, Cl, Ni — required in small amounts)
- Nitrogen fixation: biological (by Rhizobium symbiosis in root nodules of legumes; free-living Azotobacter, Anabaena, Cyanobacteria); industrial (Haber-Bosch — N₂ + 3H₂ → 2NH₃); Nitrogenase enzyme (Fe-Mo protein + Fe protein; ATP-dependent; sensitive to O₂ → leghemoglobin in nodules protects nitrogenase)
- Nitrogen cycle: N₂ fixation → NH₄⁺ (ammoniation) → NO₂⁻ → NO₃⁻ (nitrification by Nitrosomonas, Nitrobacter); NO₃⁻ → N₂ (denitrification — anaerobic bacteria); organic N → NH₄⁺ (ammonification/mineralisation)
- Mineral deficiency symptoms: N (chlorosis of older leaves), P (purple coloration — anthocyanin), K (leaf margin scorch), Ca (poor root growth; blossom end rot), Fe (chlorosis of young leaves — not re-mobilised), Mg (interveinal chlorosis — mobile), Mn (grey speck in oats), Zn (little leaf, rosette), B (death of growing points)
Water and Solute Transport
- Water potential (Ψw) = Ψs (solute/osmotic potential — always negative) + Ψp (pressure potential); water moves from high Ψw to low Ψw
- Pathways in root: Apoplastic (through cell walls — blocked at Casparian strip of endodermis for ions); Symplastic (through cytoplasm and plasmodesmata); Transmembrane (through cell membranes + plasmodesmata)
- Casparian strip: suberin-impregnated strip in endodermal cell walls; forces all water and ions through symplast → selective uptake control
- Transpiration pull: evaporation from mesophyll cells → negative pressure in xylem → water pulled up (SPAC — Soil-Plant-Atmosphere Continuum); Cohesion-Tension theory (Dixon and Joly 1894)
- Stomatal aperture control: K⁺ uptake into guard cells → water uptake → guard cell swelling → stomata open; ABA reverses by causing K⁺ efflux; CO₂ sensors; blue light (phototropin receptor) opens stomata; circadian rhythm
- Phloem transport (source → sink): sucrose loaded into phloem (companion cells → sieve elements) at source (mature leaf) → pressure-flow hypothesis — high turgor at source, low at sink → mass flow; unloading at sink (root, fruit, seed)
6.4 Plant Responses to Environment
- Photoperiodism: flowering response to relative length of light and dark periods; Long-Day Plants (LDP — flower when night < critical length: spinach, wheat); Short-Day Plants (SDP — flower when night > critical length: soybean, rice, chrysanthemum); Day-neutral plants (tomato, maize)
- Phytochrome (Pr/Pfr system): Pr (absorbs red light 660 nm → Pfr); Pfr (absorbs far-red 730 nm → Pr); Pfr promotes flowering in LDP, inhibits in SDP; night break effect; cytoplasmic and nuclear signaling (PIF — phytochrome interacting factors)
- Vernalisation: requirement for prolonged cold (0–7°C) to flower; epigenetic — FLC gene silenced by H3K27me3 during cold → FT expressed → flowering
- Photomorphogenesis: skotomorphogenesis (dark — etiolated, long hypocotyl, closed cotyledons); photomorphogenesis (light — short hypocotyl, open green cotyledons, COP1 ubiquitin ligase degraded in light)
- Tropisms: Phototropism (towards light — phototropin receptor in shoots; auxin redistribution); Gravitropism (roots: statoliths in columella cells fall to lower side → auxin redistribution → lower side grows slower in roots; shoots — opposite response); Thigmotropism (touch response — tendril coiling; seismonasty in Mimosa)
- Seed dormancy and germination: ABA enforces dormancy; GA breaks dormancy; light (phytochrome for small seeds); stratification (cold treatment); scarification; imbibition → activation of enzymes → α-amylase production (GA-dependent in aleurone)
Unit 7 — Paper II
U7 System Physiology — Animal
7.1 Blood and Circulatory System
- Blood components: Plasma (55% — water, proteins: albumin [oncotic pressure], globulins [antibodies], fibrinogen [clotting], clotting factors, hormones, nutrients); RBCs/Erythrocytes (45% — biconcave disc, no nucleus, no mitochondria in mammals; haemoglobin; 120 day lifespan; destroyed in spleen); WBCs/Leucocytes; Platelets (thrombocytes — clotting)
- Haemoglobin (Hb): α₂β₂ tetramer; Fe²⁺-porphyrin (haem) in each subunit; cooperative O₂ binding (sigmoidal curve — Hill coefficient n=2.8); T state (deoxy — low O₂ affinity); R state (oxy — high O₂ affinity)
- Bohr effect: ↑ CO₂ or ↓ pH → right shift of O₂-Hb dissociation curve → ↓ O₂ affinity → O₂ released to respiring tissues; H⁺ + Hb-O₂ → Hb-H⁺ + O₂
- 2,3-BPG (bisphosphoglycerate): allosteric effector; binds β-chain cleft of deoxy-Hb (T state); right shifts curve; ↑ at high altitude → helps release O₂; fetal Hb (HbF, α₂γ₂) binds 2,3-BPG less → higher O₂ affinity than maternal HbA → O₂ transfer across placenta
- CO₂ transport: 70% as HCO₃⁻ (CO₂ + H₂O ⇌ H₂CO₃ ⇌ H⁺ + HCO₃⁻ — catalysed by carbonic anhydrase in RBCs; Cl⁻/HCO₃⁻ exchange — chloride shift); 23% as carbaminohaemoglobin; 7% dissolved in plasma
- Blood clotting cascade: Extrinsic (TF/Factor VII — activated by vessel injury) and Intrinsic (Factor XII/XI/IX/VIII — contact activation) pathways → Common pathway (X → Xa → prothrombin → thrombin → fibrinogen → fibrin → Factor XIII crosslinks fibrin); Vitamin K required for factors II, VII, IX, X (γ-carboxylation)
- Anticoagulants: Heparin (activates antithrombin III); Warfarin (Vitamin K antagonist); Aspirin (inhibits COX → reduced thromboxane A₂ → less platelet aggregation); tPA (tissue plasminogen activator — breaks clots → plasmin → fibrinolysis)
Cardiovascular Physiology
- Cardiac cycle: Systole (contraction) → diastole (relaxation); SA node (pacemaker — 70 bpm) → AV node (delay 0.1s) → Bundle of His → Purkinje fibres → ventricular muscle; action potential: depolarisation (Na⁺ fast influx) → plateau (Ca²⁺ influx from L-type channels → triggers SR Ca²⁺ release — CICR → contraction) → repolarisation (K⁺ efflux)
- Cardiac output: CO = Stroke Volume × Heart Rate; Starling's Law — increased venous return → increased stretch of ventricle → increased force of contraction (heterometric autoregulation)
- Blood pressure: systolic/diastolic; mean arterial pressure = diastolic + 1/3 pulse pressure; regulated by baroreceptors (aortic arch, carotid sinus) → autonomic nervous system + renin-angiotensin-aldosterone system (RAAS): renin (juxtaglomerular cells) → angiotensinogen → Ang I → ACE → Ang II → vasoconstriction + aldosterone (Na⁺/water retention) → ↑ BP
7.2 Digestive System
- Digestion: Mouth (salivary amylase — starch → dextrins; lysozyme); Stomach (HCl + pepsin — protein denaturation and pepsin activation; gastric lipase; intrinsic factor for B₁₂); Small intestine (main site); Large intestine (water absorption; microbial fermentation; vitamins K and B₁₂ from bacteria)
- Pancreatic enzymes (secreted as zymogens): Trypsinogen → trypsin (by enterokinase/enteropeptidase); trypsin activates all others: chymotrypsinogen → chymotrypsin; proelastase → elastase; procarboxypeptidase A/B → carboxypeptidase; pancreatic lipase (requires colipase); pancreatic amylase; ribonuclease, DNase
- Bile: made by liver, stored in gallbladder; bile salts (cholate, deoxycholate — emulsify fats → micelle formation → lipase access); bilirubin (haem catabolism product — conjugated by UDP-glucuronosyltransferase → water-soluble; excreted in bile → stercobilin in faeces; some re-absorbed → urobilinogen in urine)
- Fat absorption: long-chain FA + monoacylglycerol → chylomicron (assembled in intestinal cell) → lymph → blood; medium chain FA directly into portal blood; fat-soluble vitamins absorbed with fats
- GI hormones: Gastrin (G cells of stomach antrum — stimulates HCl, pepsin; stimulated by food, vagus); CCK (I cells of duodenum — gallbladder contraction, pancreatic enzyme secretion; stimulated by fat + protein); Secretin (S cells — pancreatic HCO₃⁻ secretion; stimulated by acid); GIP (K cells — insulin secretion; inhibits gastric motility); GLP-1 (L cells — incretin effect; GLP-1 receptor agonists like semaglutide for diabetes/obesity)
- Energy balance and BMR: Hypothalamus regulates appetite; Leptin (adipocyte — satiety); Ghrelin (stomach — hunger — rises before meals); Insulin (anabolic; promotes fat storage); NPY/AgRP (orexigenic hypothalamic neurons); POMC/CART (anorexigenic)
7.3 Respiratory System
- Lungs: right lung (3 lobes), left lung (2 lobes); bronchi → bronchioles → alveoli (300 million, surface area ~70 m²); type I pneumocytes (gas exchange); type II pneumocytes (surfactant — dipalmitoylphosphatidylcholine — reduces surface tension, prevents collapse)
- Respiratory mechanics: inspiration (active — diaphragm + external intercostals contract → ↑ thoracic volume → ↓ pressure → air in); expiration (passive at rest — elastic recoil; active in forced expiration — internal intercostals + abdominals)
- Lung volumes: Tidal Volume (TV) ~500 mL; Inspiratory Reserve Volume (IRV) ~3000 mL; Expiratory Reserve Volume (ERV) ~1200 mL; Residual Volume (RV) ~1200 mL (cannot be expelled); Vital Capacity (VC) = TV + IRV + ERV; Total Lung Capacity (TLC) = VC + RV
- Gas exchange: Fick's law: rate = (P₁–P₂) × A × D/T (diffusing capacity); partial pressure gradients: alveolar pO₂ ~100 mmHg → pulmonary capillary ~40 mmHg (venous) → equilibrates to ~100 mmHg; pCO₂ reverse gradient
- Control of breathing: Pre-Bötzinger complex (medullary rhythm generator); chemoreceptors: Central (medullary surface — responds to pH/pCO₂; pCO₂ is primary stimulus); Peripheral (carotid and aortic bodies — respond to pO₂, pCO₂, pH; hypoxic drive)
- Respiratory disorders: Obstructive (↓ FEV₁/FVC ratio — asthma, COPD, emphysema); Restrictive (↓ FVC, normal FEV₁/FVC — pulmonary fibrosis, sarcoidosis)
7.4 Excretory System
- Kidney anatomy: cortex (glomeruli, PCT, DCT); medulla (loop of Henle, collecting duct); nephron (functional unit — ~1 million per kidney)
- Nephron function — four processes:
Glomerular filtrationStarling forces drive plasma ultrafiltrate into Bowman's space; GFR ~125 mL/min (180 L/day filtered); filtration barrier: fenestrated endothelium + GBM + podocyte slit diaphragm; negative charge repels proteins; regulated by JG apparatus
Tubular reabsorptionPCT: 65–70% Na⁺/water, all glucose (SGLT2), amino acids, HCO₃⁻, urea; Loop of Henle: water (descending — aquaporins), Na⁺/K⁺/Cl⁻ (ascending — NKCC2 — furosemide target); DCT: Ca²⁺ (PTH-regulated), Na⁺/Cl⁻ (thiazide target); Collecting duct: Na⁺ (aldosterone → ENaC), water (ADH → aquaporin-2)
Tubular secretionPCT: H⁺, organic acids/bases, drugs; DCT: K⁺ (aldosterone), H⁺ (intercalated cells — type A secretes H⁺ in acidosis, type B secretes HCO₃⁻ in alkalosis)
Concentration mechanismCountercurrent multiplier (loop of Henle) + countercurrent exchanger (vasa recta) → medullary osmotic gradient (300–1200 mOsm); ADH (vasopressin — V2 receptor → cAMP → AQP2 insertion → water reabsorption → concentrated urine)
- Acid-base balance: kidneys excrete H⁺ (as NH₄⁺ and titratable acid) and reabsorb HCO₃⁻; Bicarbonate buffer is main blood buffer; respiratory compensation within minutes; renal compensation takes days
- Acid-base disorders: Metabolic acidosis (↓ pH, ↓ HCO₃⁻ — diabetic ketoacidosis, renal failure); Metabolic alkalosis (↑ pH, ↑ HCO₃⁻ — vomiting, diuretics); Respiratory acidosis (↓ pH, ↑ pCO₂ — COPD, hypoventilation); Respiratory alkalosis (↑ pH, ↓ pCO₂ — hyperventilation, high altitude)
- Juxtaglomerular apparatus: JG cells (modified smooth muscle of afferent arteriole — secrete renin); macula densa (DCT cells sensing Na⁺ delivery — regulate renin and GFR); mesangial cells; regulates GFR via tubuloglomerular feedback
7.5 Nervous System
- Neuron structure: cell body (soma) + dendrites (receive signals) + axon (transmit to presynaptic terminal); myelinated axons (Schwann cells in PNS; oligodendrocytes in CNS; saltatory conduction at nodes of Ranvier)
- Resting membrane potential: –70 mV (inside negative); maintained by Na⁺/K⁺-ATPase (3 Na⁺ out, 2 K⁺ in) + selective K⁺ permeability (K⁺ leaks out through K⁺ leak channels)
- Action potential: Threshold (–55 mV) → rapid depolarisation (voltage-gated Na⁺ channels open → Na⁺ influx) → overshoot (+40 mV) → repolarisation (Na⁺ channels inactivate; voltage-gated K⁺ channels open → K⁺ efflux) → undershoot/hyperpolarisation (K⁺ channels slow to close) → refractory period (absolute: Na⁺ channels inactivated; relative: hyperpolarised); All-or-none principle
- Synaptic transmission: Action potential → Ca²⁺ influx (VGCC) → vesicle fusion (SNARE proteins: SNAP-25, Synaptobrevin, Syntaxin) → neurotransmitter release → diffuses across cleft → postsynaptic receptor → response; neurotransmitter termination: reuptake (SERT for serotonin — SSRIs block; DAT for dopamine), enzymatic degradation (AChE for ACh), diffusion
| Neurotransmitter | Source | Receptors | Function | Disease Link |
|---|---|---|---|---|
| Acetylcholine (ACh) | Motor neurons, basal forebrain, autonomic preganglionic | Nicotinic (ionotropic — Na⁺/K⁺); Muscarinic M1–M5 (metabotropic) | Neuromuscular junction; memory; autonomic | Myasthenia gravis (anti-nAChR Ab); Alzheimer (↓ACh in basal forebrain); botulinum toxin blocks release |
| Dopamine (DA) | Substantia nigra (nigrostriatal); VTA (mesolimbic, mesocortical); hypothalamus | D1-D5 (all metabotropic — GPCRs) | Motor control; reward; motivation; working memory; prolactin inhibition | Parkinson (↓DA in nigrostriatal); Schizophrenia (↑DA in mesolimbic); L-DOPA treatment |
| Serotonin (5-HT) | Raphe nuclei (brainstem) | 5-HT1–7 (mostly metabotropic; 5-HT3 ionotropic) | Mood; sleep; appetite; GI motility; blood vessel tone | Depression (↓5-HT — SSRIs increase synaptic 5-HT); migraine; 5-HT syndrome |
| GABA | Widespread inhibitory interneurons | GABA-A (Cl⁻ channel — ionotropic); GABA-B (metabotropic — K⁺ channel) | Major inhibitory NT in CNS; reduces neuronal excitability | Epilepsy (↓GABA); anxiety; benzodiazepines/barbiturates potentiate GABA-A; vigabatrin inhibits GABA-T |
| Glutamate | Widespread excitatory neurons | AMPA, NMDA, Kainate (ionotropic); mGluR (metabotropic) | Major excitatory NT in CNS; learning and memory (LTP — NMDA receptor) | Excitotoxicity (stroke, TBI); Memantine (NMDA antagonist) in Alzheimer |
| Noradrenaline (NE) | Locus coeruleus; sympathetic neurons | α1, α2, β1, β2, β3 (all metabotropic) | Arousal; fight-or-flight; attention; sympathetic; blood pressure | Depression (↓NE — TCAs, SNRIs); ADHD (norepinephrine reuptake inhibitor atomoxetine) |
Sense Organs
- Vision: Rods (rhodopsin — 11-cis retinal + opsin; absorbs ~500 nm; dim light/scotopic; no colour); Cones (three types: L/M/S — red/green/blue; photopic; colour vision); Phototransduction: light → 11-cis retinal → all-trans retinal → opsin activation → transducin (Gαt) → activates PDE → ↓ cGMP → cGMP-gated channels close → hyperpolarisation (unique — light causes hyperpolarisation not depolarisation) → reduced glutamate release → bipolar cells → ganglion cells → optic nerve
- Hearing: Sound waves → tympanic membrane → ossicles (malleus-incus-stapes) → oval window → cochlea (scala vestibuli-scala media-scala tympani); basilar membrane vibrates — tonotopic organisation (base = high freq; apex = low freq); hair cells (stereocilia) — tip links open mechanosensitive channels → K⁺ influx (endolymph is K⁺ rich) → depolarisation → glutamate release → auditory nerve (cranial nerve VIII)
- Tactile response: Meissner's corpuscles (light touch, edge detection); Pacinian corpuscles (vibration, deep pressure); Ruffini endings (skin stretch); Merkel discs (fine touch, sustained pressure); Free nerve endings (pain, temperature)
7.6 Endocrine System
| Gland | Hormone | Action | Disorder |
|---|---|---|---|
| Hypothalamus | TRH, CRH, GnRH, GHRH, somatostatin, dopamine, oxytocin, ADH (made here, stored in post. pituitary) | Releasing/inhibiting hormones for anterior pituitary; ADH (water reabsorption); Oxytocin (uterine contraction, milk ejection) | Diabetes insipidus (↓ADH or resistance) |
| Anterior pituitary | TSH, ACTH, FSH, LH, GH, Prolactin | Tropic hormones (stimulate target glands); GH (IGF-1 production, growth, lipolysis, anti-insulin); Prolactin (lactation) | Acromegaly (↑GH adult); Gigantism (↑GH child); Panhypopituitarism |
| Thyroid | T₃ (triiodothyronine — active), T₄ (thyroxine — prohormone), Calcitonin (C cells) | T₃/T₄: metabolic rate ↑; growth; brain development; cardiac output ↑; Calcitonin: ↓ serum Ca²⁺ (minor role) | Hypothyroidism (Hashimoto — autoimmune); Hyperthyroidism (Graves disease — TSH receptor Ab) |
| Parathyroid | PTH (Parathyroid hormone) | ↑ serum Ca²⁺: bone resorption (osteoclast activation); renal Ca²⁺ reabsorption; ↑ Vitamin D activation (1α-hydroxylase in kidney); ↓ phosphate reabsorption | Hypoparathyroidism → tetany; Hyperparathyroidism → hypercalcaemia, osteoporosis, kidney stones |
| Adrenal cortex | Glucocorticoids (Cortisol — zona fasciculata); Mineralocorticoids (Aldosterone — zona glomerulosa); Androgens (DHEA — zona reticularis) | Cortisol: anti-inflammatory; ↑ gluconeogenesis; lipolysis; immunosuppression; stress response; Aldosterone: Na⁺ retention, K⁺ excretion (↑ ENaC and Na⁺/K⁺-ATPase) | Cushing syndrome (↑ cortisol); Addison disease (↓ all adrenocortical hormones — hyperpigmentation due to ↑ ACTH/MSH) |
| Adrenal medulla | Adrenaline (Epinephrine) 80%; Noradrenaline 20% | Fight-or-flight: ↑ HR, ↑ BP, bronchodilation, ↑ glucose (glycogenolysis), ↑ lipolysis; pupil dilation; piloerection; ↓ GI motility | Phaeochromocytoma (catecholamine-secreting tumour) |
| Pancreas (Islets of Langerhans) | Insulin (β cells); Glucagon (α cells); Somatostatin (δ cells) | Insulin: ↑ glucose uptake (GLUT4 translocation — muscle/fat), glycogenesis, lipogenesis, protein synthesis; Glucagon: glycogenolysis, gluconeogenesis, lipolysis, ketogenesis; Somatostatin: inhibits both | Type 1 DM (autoimmune β-cell destruction); Type 2 DM (insulin resistance) |
| Gonads | Oestrogen, Progesterone (ovary); Testosterone (testis) | Sexual development; menstrual cycle; spermatogenesis; secondary sexual characters; bone density | Turner syndrome (↓ oestrogen); Klinefelter (↓ testosterone); Polycystic ovary syndrome (PCOS) |
| Pineal | Melatonin | Circadian rhythm (light inhibits — dark stimulates melatonin synthesis); sleep initiation; seasonal reproduction in animals | Jet lag; sleep disorders |
Insulin secretion mechanism (KATP channel model): glucose enters β-cell via GLUT2 → glycolysis + TCA → ↑ ATP/ADP ratio → KATP channel closes → membrane depolarises → voltage-gated Ca²⁺ channels open → Ca²⁺ influx → insulin vesicle exocytosis. Sulphonylureas (e.g., glibenclamide) close KATP channels directly → ↑ insulin secretion (Type 2 DM treatment).
7.7 Reproductive System and Physiology
- Menstrual cycle (28 days): Follicular phase (Day 1–14): FSH → follicle development → oestrogen ↑ → LH surge (mid-cycle, day 14) → Ovulation; Luteal phase (Day 14–28): LH → corpus luteum → progesterone + oestrogen ↑ → endometrium prepares; if no fertilisation → corpus luteum degenerates → progesterone ↓ → menstruation
- Puberty: GnRH pulse frequency increases → LH and FSH → gonadal steroid production; menarche (first menstruation); spermarche (first ejaculation); Tanner stages
- Menopause: ovarian follicle depletion → ↓ oestrogen and progesterone → ↑ FSH and LH (no negative feedback); hot flushes; osteoporosis risk; CVD risk increases; vaginal atrophy; average age 51 years
- Spermatogenesis: seminiferous tubules; spermatogonia → primary spermatocyte (meiosis I) → secondary spermatocyte (meiosis II) → spermatids → spermatozoa (spermiogenesis); ~70–74 days; temperature-sensitive (3°C below body — cryptorchidism → infertility)
- Oogenesis: all primary oocytes present at birth (arrested in Prophase I); resume meiosis at puberty (one per cycle); arrested at Metaphase II until fertilisation; asymmetric divisions → large egg + small polar bodies; only ~400 oocytes ovulated in lifetime
- Fertilisation and implantation: capacitation of sperm; acrosome reaction at zona pellucida; sperm-egg fusion; blocks to polyspermy; zygote → cleavage → morula → blastocyst → implants in endometrium (Day 6–7); hCG produced by trophoblast → maintains corpus luteum → early pregnancy
- Placenta: chorioallantoic; chorionic villi exchange O₂, nutrients, waste; barrier to large molecules, many pathogens (but rubella, CMV, Toxoplasma, HIV cross); produces oestrogen, progesterone (from 12 weeks → replaces corpus luteum), hCG, hPL
Unit 8 — Paper II
U8 Inheritance Biology
8.1 Mendelian Genetics
- Mendel's Laws: Law of Segregation (two alleles of a gene separate during gamete formation; each gamete receives one allele); Law of Independent Assortment (alleles of different genes assort independently — only true for non-linked genes)
- Monohybrid cross: Aa × Aa → 1 AA : 2 Aa : 1 aa (genotype 1:2:1; phenotype 3:1 for complete dominance)
- Test cross: Aa × aa → 1 Aa : 1 aa (1:1 ratio — identifies whether dominant phenotype is AA or Aa)
- Dihybrid cross: AaBb × AaBb → 9:3:3:1 (A_B_ : A_bb : aaB_ : aabb)
Extensions to Mendelian Genetics
Incomplete dominanceHeterozygote intermediate; Rr (red) × Rr (red) → 1 RR (red) : 2 Rr (pink) : 1 rr (white); phenotype 1:2:1; example: snapdragon flower colour
CodominanceBoth alleles expressed in heterozygote; ABO blood groups — A and B both expressed in AB type; sickle cell trait — both HbA and HbS produced
Multiple allelesMore than two alleles exist in population for one locus; ABO blood groups (I^A, I^B, i — 3 alleles); each individual has only 2; I^A and I^B both dominant over i; codominant to each other
EpistasisOne gene masks expression of another; Recessive epistasis (9:3:4 — Labrador coat); Dominant epistasis (12:3:1); Duplicate recessive epistasis (9:7); Duplicate dominant epistasis (15:1); Albinism — cc (tyrosinase –) masks all pigment regardless of other genes
PleiotropyOne gene affects multiple characters; Sickle cell anaemia (HBB gene — affects RBC shape, O₂ transport, spleen, kidney, joints, brain); Marfan syndrome (FBN1 — tall, long fingers, aortic aneurysm, lens dislocation)
Penetrance and expressivityPenetrance: proportion of individuals with genotype who show phenotype; Expressivity: degree of phenotype expression; modified by environment + other genes; polydactyly (variable expressivity)
Quantitative traits/Polygenic inheritanceMany genes + environment → continuous phenotypic distribution; height, weight, skin colour, IQ; normal distribution; heritability (h²) = genetic variance/total phenotypic variance
8.2 Linkage, Recombination and Chromosome Mapping
- Linkage: genes on same chromosome tend to be inherited together (violate Law of Independent Assortment); coupling vs repulsion; linkage detected by deviation from 1:1:1:1 ratio in test cross of dihybrid
- Recombination frequency: RF = (recombinant progeny / total progeny) × 100%; 1% RF = 1 centimorgan (cM) = 1 map unit; RF maximum = 50% (for unlinked genes or genes far apart)
- Three-point cross: order three genes by determining which gene is in middle (double crossovers reveal middle gene); calculate map distances from each interval; positive interference — observed DCO less than expected; I = 1 – (observed DCO/expected DCO)
- Chromosome mapping: uses recombination frequencies between pairs of genes; maps are not always additive (double crossovers); LOD score (Log of Odds ratio) for human linkage analysis — threshold >3.0 suggests linkage
8.3 Sex Determination and Sex-Linked Inheritance
- XX/XY system (humans, Drosophila): SRY gene on Y chromosome → TDF (testis-determining factor) → male development; XO (Turner syndrome — female phenotype, sterile); XXY (Klinefelter — male phenotype, infertile); XXX (triple X — normal female)
- ZW/ZZ system (birds, some fish and insects): females are ZW; males are ZZ; opposite of XX/XY
- Haplo-diploid sex determination (Hymenoptera — bees, ants, wasps): males from unfertilised eggs (haploid); females from fertilised eggs (diploid); determines sex by ploidy, not sex chromosomes
- X-linked recessive inheritance: haemophilia A (Factor VIII — F8 gene); haemophilia B (Factor IX); colour blindness (OPN1LW, OPN1MW); Duchenne muscular dystrophy (dystrophin); G6PD deficiency; more common in males (XY — only one copy); females can be carriers (XX — heterozygous)
- X-linked dominant inheritance: Fragile X syndrome (FMR1 gene — CGG repeat expansion > 200 — leading cause of inherited intellectual disability); Rett syndrome (MECP2); vitamin D-resistant rickets
- Y-linked (Holandric) inheritance: father → all sons; Y chromosome (SRY, AZF — azoospermia factor, testis-specific genes)
- X-inactivation (Lyon hypothesis): one X randomly inactivated in each somatic cell of female → Barr body (condensed inactive X); epigenetically maintained by XIST RNA coating inactive X + H3K27me3; mosaicism in X-linked traits (calico cat coat colour)
- Dosage compensation: equalise gene expression between XX and XY; achieved by X-inactivation in mammals; hyperactivation of single X in Drosophila (MSL complex doubles transcription rate of X in males); chromosome-wide transcriptional silencing in C. elegans
8.4 Chromosomal Abnormalities and Human Genetics
Numerical Abnormalities (Aneuploidy)
| Condition | Karyotype | Features | Cause |
|---|---|---|---|
| Down syndrome | Trisomy 21 (47, XX/XY, +21) | ID, flat face, upslanting palpebral fissures, short stature, single palmar crease, congenital heart disease (AVSD), ↑ Alzheimer risk (extra APP gene) | Non-disjunction in meiosis I of oogenesis; maternal age effect (1:1500 at 20yr; 1:30 at 45yr); 95% free trisomy, 4% translocation (Robertsonian), 1% mosaic |
| Edwards syndrome | Trisomy 18 (47, XX/XY, +18) | Severe ID, clenched fists (overlapping fingers), rocker-bottom feet, micrognathia, heart defects; poor prognosis (<10% survive 1 year) | Non-disjunction; maternal age effect |
| Patau syndrome | Trisomy 13 (47, XX/XY, +13) | Holoprosencephaly, cleft lip/palate, polydactyly, eye defects; poor prognosis | Non-disjunction |
| Turner syndrome | 45, X (monosomy X) | Short stature, primary amenorrhoea (streak ovaries), webbed neck, coarctation of aorta, infertile; normal intelligence; most common sex chromosome disorder | Loss of X from father (non-disjunction); most conceptuses 45,X are aborted |
| Klinefelter syndrome | 47, XXY | Tall, small testes (hypogonadism), infertile (azoospermia), gynaecomastia, learning difficulties; often undiagnosed | Non-disjunction during meiosis I or II |
Structural Chromosomal Abnormalities
- Deletions: cri-du-chat syndrome (5p– deletion → cat-like cry in infants, ID); DiGeorge syndrome (22q11.2 deletion → conotruncal heart defects, immunodeficiency, hypoparathyroidism)
- Inversions: Paracentric (doesn't include centromere; dicentric chromatids if crossing over within inversion); Pericentric (includes centromere)
- Translocations: Reciprocal (exchange between two non-homologous chromosomes); Robertsonian (fusion of two acrocentric chromosomes at centromere — 13, 14, 15, 21, 22; carrier has 45 chromosomes; risk of Down syndrome in offspring)
- Fragile sites: cytogenetically visible constrictions; Fragile X: FRAXA — CGG repeat (>200 → FMR1 methylation → silencing → loss of FMRP → X-linked intellectual disability)
Mutation and Mutagenesis
- Point mutations: Transition (purine→purine or pyrimidine→pyrimidine: A→G, C→T); Transversion (purine↔pyrimidine: A→C, G→T); Missense (codon → different AA — conservative if similar AA; non-conservative if different); Nonsense (codon → stop codon); Silent/synonymous (codon → same AA — wobble)
- Frameshift mutations: insertion or deletion of non-multiples of 3 → shift reading frame → garbled protein to next stop codon
- Trinucleotide repeat expansion: CGG in Fragile X (>200 repeats); CAG in Huntington disease (>36 repeats → polyQ → aggregates); CTG in myotonic dystrophy; anticipation — expansion increases in successive generations
- Physical mutagens: UV (pyrimidine dimers); ionising radiation (X-rays, γ-rays → DSBs, depurination); chemical mutagens: alkylating agents (EMS, MMS), base analogues (5-BU, 2-AP), intercalating agents (acridine orange, ethidium bromide → frameshift), oxidising agents (ROS)
- Ames test: tests chemical mutagenicity using His⁻ Salmonella typhimurium → if chemical mutates bacteria → growth on His⁻ medium → mutagenic (also often carcinogenic); includes rat liver extract (S9) to include metabolic activation
8.5 Recombinant DNA Technology
- Restriction enzymes (Type II): recognise specific palindromic sequences (4–8 bp); cut both strands → blunt or sticky ends; EcoRI (GAATTC → 5' AATT overhang); HindIII (AAGCTT → 5' AGCT); BamHI (GGATCC)
- Vectors: Plasmid (small circular DNA; ori + antibiotic resistance gene + MCS; up to ~10 kb insert); Bacteriophage (λ phage — 10–20 kb; M13 for ssDNA); Cosmid (plasmid + cos sites of λ; 35–45 kb); YAC (Yeast Artificial Chromosome; large inserts 200–1000 kb — used for Human Genome Project); BAC (Bacterial AC; 100–300 kb; more stable than YAC); Virus vectors (retrovirus, lentivirus, adenovirus, AAV for gene therapy)
- cDNA library: mRNA → reverse transcriptase → cDNA; represents expressed genes only (no introns); useful for eukaryotic gene expression in bacteria
- Genomic library: total genomic DNA cut with restriction enzyme → all sequences including introns and non-coding regions; complete but contains much non-coding DNA
- Polymerase Chain Reaction (PCR): in vitro DNA amplification; Denaturation (94°C) → Annealing (50–65°C, primers bind) → Extension (72°C, Taq polymerase extends 3'→5'); exponential amplification (2ⁿ copies after n cycles); applications: diagnostics (PCR of HIV, COVID-19), genotyping, forensics, quantitative PCR (qPCR/RT-PCR — measure gene expression)
- DNA sequencing: Sanger (dideoxy chain termination — ddNTPs stop extension; gel or capillary electrophoresis; gold standard but slow); Next-Generation Sequencing (NGS — Illumina: bridge amplification → sequencing by synthesis → massive parallel; Nanopore: real-time single molecule; long reads); WGS (whole genome), WES (whole exome), RNA-seq, ChIP-seq, ATAC-seq
CRISPR-Cas9 Genome Editing
- Cas9 (CRISPR-associated protein 9): endonuclease from Streptococcus pyogenes (SpCas9); guided by sgRNA (single guide RNA = crRNA + tracrRNA); recognises PAM (Protospacer Adjacent Motif — NGG for SpCas9); creates blunt DSB 3 bp upstream of PAM
- Repair outcomes: NHEJ (error-prone → indels → gene knockout); HDR (homology-directed repair with donor template → precise edits — knockin, correction)
- Variants: Base editors (CBE — C to T; ABE — A to G; no DSB); Prime editing (pegRNA — search and replace, no DSB); CRISPRi (dCas9 + KRAB → gene repression); CRISPRa (dCas9 + VPR → gene activation); Cas12a (TTTN PAM; staggered cuts); Cas13 (RNA-targeting)
- Applications: gene therapy (haemoglobinopathies — Casgevy for sickle cell/thalassaemia, FDA approved 2023); cancer immunotherapy (CAR-T editing); model organisms; agriculture (disease-resistant crops)
- Nobel Prize: Jennifer Doudna and Emmanuelle Charpentier (2020 Chemistry Nobel) for CRISPR-Cas9 development
Transgenics and Cloning
- Transgenic organisms: contain foreign gene (transgene) stably integrated in genome; Transgenic mice (pronuclear injection or ES cell → knockout; Cre-lox — conditional knockout); Transgenic plants (Agrobacterium tumefaciens Ti plasmid; biolistics/gene gun); Applications: Bt crops (Bacillus thuringiensis Cry toxin → insect resistance), Roundup-Ready (herbicide tolerance — EPSPS), Golden Rice (β-carotene biosynthesis genes — VAD intervention)
- Gene therapy: introducing functional gene to correct deficiency; Ex vivo (modify cells outside body, reinfuse — ADA-SCID, CAR-T); In vivo (vector directly into patient — Luxturna for RPE65 retinal dystrophy, Zolgensma for SMA); challenges: immune response, off-target integration, expression duration
- Genomics: Human Genome Project (completed 2003; 3.2 billion bp; ~20,000–25,000 protein-coding genes; only 1.5% codes for protein; 45% repetitive sequences); Personalised medicine; GWAS (genome-wide association studies)
- Proteomics: study of all proteins in cell/tissue; 2D gel electrophoresis + mass spectrometry; protein-protein interactions (Y2H, co-IP, BiFC); protein structure prediction (AlphaFold — AI-based, predicted structures of >200 million proteins)
Unit 9 — Paper II
U9 Diversity of Life Forms
9.1 Three Domain System and Five Kingdom Classification
- Three domain system (Woese, 1990 — based on 16S/18S rRNA sequences): Bacteria, Archaea, Eukarya; Archaea are more closely related to Eukarya than to Bacteria; supported by phylogenetic analysis, molecular data
- Five Kingdom classification (Whittaker, 1969): Monera (prokaryotes), Protista, Fungi, Plantae, Animalia; based on cell type, body organisation, nutrition, reproduction
- Two Kingdom (Linnaeus — Plantae and Animalia) → problematic for fungi, algae, bacteria
Viruses
- Non-living (no metabolism, no reproduction without host); contain either DNA or RNA (not both); obligate intracellular parasites; classified by nucleic acid type, strandedness, replication strategy (Baltimore classification — 7 groups)
- Structure: capsid (protein coat); nucleic acid; envelope (in some — from host membrane; phospholipid bilayer with viral glycoproteins); naked viruses (no envelope)
- Bacteriophage (phage): viruses infecting bacteria; lytic cycle (replication → cell lysis → burst); lysogenic cycle (phage genome integrates as prophage → replicates with host → can be induced → lytic cycle)
- Animal viruses: Adsorption → Penetration → Uncoating → Replication → Assembly → Release; RNA viruses: +ssRNA (picornavirus, coronavirus, flavivirus — directly translated); –ssRNA (rhabdovirus, orthomyxovirus — need RNA-dependent RNA polymerase first); dsRNA (rotavirus); retroviruses (HIV — reverse transcriptase → dsDNA integrates as provirus)
- HIV: envelope with gp120 (binds CD4 + CCR5 coreceptor) and gp41 (fusion); core: two ssRNA molecules + reverse transcriptase + integrase + protease; cycle: binding → fusion → RT → integration (provirus) → transcription → assembly → budding → maturation; HAART (highly active antiretroviral therapy) targets RT, protease, integrase, fusion
- Prions: infectious protein (PrPˢᶜ — misfolded form of normal PrPᶜ); cause spongiform encephalopathies: Scrapie (sheep), BSE (bovine), CJD (Creutzfeldt-Jakob — human), kuru (ritual cannibalism); no nucleic acid; templated misfolding; Stanley Prusiner (Nobel 1997)
Bacteria
- Structure: peptidoglycan cell wall; no membrane-bound nucleus; 70S ribosomes; circular chromosome; plasmids; pili (attachment, conjugation); flagella (motility — H antigen); capsule (virulence, anti-phagocytic)
- Gram staining: Gram-positive (thick peptidoglycan — retains crystal violet → purple; e.g., Staphylococcus, Streptococcus, Bacillus, Clostridium); Gram-negative (thin PG + outer membrane with LPS — decolorised by acetone → red with safranin; e.g., E. coli, Salmonella, Pseudomonas, Neisseria); outer membrane is LPS (lipopolysaccharide) — endotoxin
- Bacterial gene transfer: Transformation (uptake of naked DNA — basis of recombinant DNA technology; Griffith's experiment); Transduction (bacteriophage transfers DNA — generalised or specialised); Conjugation (cell-cell contact via pilus → plasmid/chromosome transfer — F plasmid; F⁺ → F⁻; Hfr strains — chromosomal gene transfer)
- Antibiotic resistance mechanisms: β-lactamase (enzyme — destroys penicillin/ampicillin/cephalosporin); Modified targets (PBP2a in MRSA — penicillin-binding protein); Efflux pumps (pump antibiotic out); Reduced permeability (modified porins); Enzymatic modification (aminoglycoside resistance)
- Biofilm: bacterial community encased in extracellular polysaccharide matrix; attached to surfaces; antibiotic-resistant (up to 1000× more resistant); chronic infections; dental plaque, cystic fibrosis lung, prosthetic device infections; quorum sensing regulates biofilm formation
Fungi
- Heterotrophic (absorptive nutrition); cell wall of chitin; ergosterol in membrane (target for antifungals — amphotericin B, azoles); dikaryotic phase in Basidiomycetes and Ascomycetes
- Classification: Zygomycetes (Rhizopus — bread mould; zygospore); Ascomycetes (largest group — yeast, Aspergillus, Penicillium, morels, truffles; sexual spores in asci); Basidiomycetes (mushrooms, rusts, smuts; sexual spores on basidia)
- Mycorrhizae: mutualistic association between fungi and plant roots; Ectomycorrhizae (sheath around roots — forest trees); Endomycorrhizae/Arbuscular mycorrhizae (hyphae inside root cells — 80% of plants); benefit: ↑ P and water uptake; pathogen resistance
- Medical importance: Candida albicans (oral/vaginal thrush — dimorphic); Aspergillus fumigatus (invasive aspergillosis in immunocompromised); Cryptococcus neoformans (meningitis in AIDS — India ink capsule); Dermatophytes (Tinea — ringworm, athlete's foot — Trichophyton, Microsporum, Epidermophyton)
Protists and Algae
- Diverse eukaryotic group — polyphyletic; includes photosynthetic (algae) and heterotrophic (protozoa, slime moulds) forms
- Algae: chlorophyll a in all; additional pigments vary; Chlorophyta (green algae — Chlamydomonas, Spirogyra, Volvox; closest relatives of land plants); Phaeophyta (brown algae — Fucus, Laminaria/kelp; algin); Rhodophyta (red algae — agar, carrageenan); Chrysophyta (diatoms — silica cell wall, diatomaceous earth; major primary producers); Dinoflagellates (red tides — paralytic shellfish poisoning; bioluminescence)
- Protozoa: Sarcomastigophora (amoeba, Giardia, Trypanosoma); Apicomplexa (Plasmodium, Toxoplasma — apical complex for invasion); Ciliophora (Paramecium — conjugation; micronucleus + macronucleus)
- Plasmodium lifecycle: sporozoites (from mosquito salivary gland) → hepatocytes (liver stage — hypnozoite in P. vivax, P. ovale → relapse) → merozoites → RBCs → ring trophozoite → schizont → merozoites (rupture — fever) → gametocytes → Anopheles mosquito → sexual stage (zygote → ookinete → oocyst → sporozoites)
Unit 10 — Paper II
U10 Ecological Principles
10.1 Levels of Organisation and Energy Flow
- Ecological levels: individual → population → community → ecosystem → biome → biosphere
- Trophic levels: Producers (autotrophs — plants, algae, cyanobacteria); Primary consumers (herbivores); Secondary consumers; Tertiary consumers; Decomposers (detritivores — fungi, bacteria — break down dead organic matter)
- Food web: interconnected food chains; provides stability (if one species declines, energy flow can continue via other pathways); keystone species — disproportionate effect on ecosystem (sea otter — controls sea urchin → protects kelp forest)
- Energy flow: unidirectional; only 10% of energy passes between trophic levels (10% rule — Lindeman 1942); 90% lost as heat, respiration, uneaten biomass; Ecological Efficiency = (energy at trophic level n+1 / energy at trophic level n) × 100%
- Pyramids: Pyramid of numbers (can be inverted — trees); Pyramid of biomass (usually upright; inverted in open ocean — phytoplankton small but rapidly reproducing); Pyramid of energy (always upright — fundamental relationship)
- Primary productivity: GPP (Gross PP — total photosynthesis); NPP = GPP – Plant respiration; Net Ecosystem Production (NEP) = GPP – total ecosystem respiration; NEP >0 = carbon sink; tropical rainforests and estuaries have highest NPP
10.2 Biogeochemical Cycles
Carbon Cycle
- Photosynthesis (CO₂ fixation) ↔ Respiration (CO₂ release); decomposition; combustion of fossil fuels (adding ~10 PgC/year — exceeds natural sinks); oceanic uptake (~2.5 PgC/year); terrestrial uptake (~3.5 PgC/year); net increase ~3.5 ppm CO₂/year in atmosphere
- Greenhouse effect: CO₂, CH₄, N₂O, H₂O, ozone absorb outgoing infrared radiation → warm atmosphere; global warming; CO₂ GWP = 1 (reference); CH₄ GWP = 21 (over 100 years); N₂O GWP = 310; CFCs/HFCs — highest GWP
Nitrogen Cycle
- N₂ → NH₃ (Nitrogen fixation: Rhizobium, Azotobacter, Cyanobacteria, Anabaena; lightning; industrial Haber-Bosch); NH₃/NH₄⁺ → NO₂⁻ → NO₃⁻ (Nitrification: Nitrosomonas, Nitrobacter); NO₃⁻ → N₂ (Denitrification: Pseudomonas, Thiobacillus — anaerobic); organic N → NH₄⁺ (Ammonification by decomposers)
- Eutrophication: excessive nutrient input (N and P) → algal bloom → O₂ depletion (decomposers respire dead algae) → hypoxic dead zones → fish kills; example: Baltic Sea, Gulf of Mexico dead zone
Phosphorus Cycle
- No atmospheric reservoir (unlike C and N); weathering of phosphate rocks → dissolved phosphate → taken up by plants → food web → decomposition → soil; long-term storage in sedimentary rock; slow cycle; P often limiting nutrient in freshwater ecosystems
10.3 Population Ecology
- Population parameters: size (N), density, birth rate (b), death rate (d), immigration (i), emigration (e); dN/dt = (b + i) – (d + e)
- Exponential growth: dN/dt = rN; r = intrinsic rate of natural increase (b – d); occurs when resources unlimited; J-shaped curve; characteristic of invasive species, bacteria in favourable conditions
- Logistic growth: dN/dt = rN(K–N)/K; K = carrying capacity; S-shaped (sigmoidal) curve; population stabilises at K; density-dependent factors increase at high density (food competition, predation, disease, stress)
- Life history strategies: r-strategists (high r, many small offspring, little parental care, short lifespan — insects, weeds, mice; early colonisers); K-strategists (low r, few large offspring, extensive parental care, long lifespan — elephants, humans, trees; stable environments)
- Age structure: pre-reproductive, reproductive, post-reproductive; growing populations have large pre-reproductive cohort; declining populations have more post-reproductive; demographic transition
- Survivorship curves: Type I (high juvenile survival, most die of old age — humans, elephants); Type II (constant mortality across all ages — birds, many lizards); Type III (high early mortality, few survivors reproduce — oak trees, fish, most invertebrates)
10.4 Community Ecology and Succession
- Species interactions: Mutualism (+/+); Commensalism (+/0); Amensalism (–/0); Predation (+/–); Parasitism (+/–); Competition (–/–)
- Competitive Exclusion Principle (Gause's Law): two species competing for identical resources cannot coexist at stable equilibrium; one will be excluded; BUT niche differentiation allows coexistence
- Resource partitioning: sympatric species divide resources to avoid competition; Darwin's finches (beak size and food type); warblers (different foraging zones in spruce trees — MacArthur)
- Ecological niche: fundamental niche (physiological tolerance range — no competitors); realised niche (actual use in presence of competitors — smaller); hypervolume model (Hutchinson) — n-dimensional
- Predator-Prey dynamics: Lotka-Volterra equations; coupled oscillations (prey peaks → predator increases → prey declines → predator declines → prey recovers); Isle Royale (wolves and moose — classic example); top-down control (trophic cascade)
- Succession: Primary succession (bare substrate — no soil; e.g., bare rock, volcanic island — pioneer species: lichens, mosses → soil formation → grasses → shrubs → climax); Secondary succession (disturbed but soil intact — faster; abandoned field, fire, logging); Climax community (stable end state — debated; Clements vs Gleason view)
10.5 Biodiversity and Conservation
- Biodiversity levels: Genetic diversity (within species); Species diversity (alpha diversity — within habitat; beta diversity — between habitats; gamma diversity — overall landscape); Ecosystem diversity
- Biodiversity indices: Species richness (S); Shannon-Weiner diversity index H' = –Σ(pᵢ ln pᵢ); Simpson's index (D = Σnᵢ(nᵢ–1)/N(N–1)); Evenness (E = H'/H'max)
- Global biodiversity hotspots: 36 hotspots; must have ≥1500 endemic vascular plants AND ≥70% original habitat lost; India: Western Ghats + Sri Lanka; Eastern Himalayas; Indo-Burma
- IUCN Red List categories: Extinct (EX); Extinct in Wild (EW); Critically Endangered (CR — 80% decline in 10 years or 3 generations); Endangered (EN — 50% decline); Vulnerable (VU — 30% decline); Near Threatened (NT); Least Concern (LC)
- Major threats to biodiversity (HIPPO mnemonic): Habitat loss (most important — deforestation, agriculture, urban expansion); Invasive species; Pollution; Population (human); Overexploitation (hunting, poaching, overfishing)
- Conservation strategies: In situ (within natural habitat — national parks, sanctuaries, biosphere reserves, community reserves, Conservation Reserves); Ex situ (zoos, gene banks, seed banks — Svalbard Global Seed Vault; botanical gardens; cryopreservation)
- Protected areas in India: 106 National Parks; 567 Wildlife Sanctuaries; 18 Biosphere Reserves (12 in UNESCO MAB network); Project Tiger (1973 — now 54 tiger reserves; tiger population: ~3,167 in 2022); Project Elephant (1992); Operation Crocodile; Saving the Great Indian Bustard
- International agreements: CBD (Convention on Biological Diversity — 1992 Rio Earth Summit); CITES (Convention on International Trade in Endangered Species); RAMSAR (wetlands); IUCN; CMS (Migratory Species)
India's biodiversity: 7th largest country by area but accounts for 8% of global species diversity; 33% of flowering plants are endemic; 4 of 36 global biodiversity hotspots; 91,212 animal species and 45,500 plant species described. India is a megadiverse country — one of 17 nations designated as such.
10.6 Environmental Issues
- Pollution types: Air (SO₂, NOₓ — acid rain; CO, PM₂.₅, PM₁₀, VOCs, O₃ — smog; AQI in India; NAAQS); Water (BOD — Biochemical Oxygen Demand; COD; heavy metals — Hg, Pb, Cd, As; pesticides; eutrophication); Soil (heavy metals, industrial effluents, plastic); Noise (decibels; WHO: <40 dB night outdoors, <70 dB workday); Radioactive (uranium mining, nuclear power, medical waste)
- Ozone depletion: Stratospheric ozone (O₃) absorbs UV-B and UV-C; CFCs (chlorofluorocarbons) → Cl• radicals → catalytically destroy O₃ (Cl• + O₃ → ClO + O₂; ClO + O → Cl• + O₂; one Cl• can destroy 100,000 O₃ molecules); Montreal Protocol (1987) — phase-out of CFCs; ozone hole recovery expected by 2065
- Climate change: ↑ CO₂ (from 280 ppm pre-industrial → 420 ppm 2023); global average temperature ↑1.1°C; consequences: sea level rise, glacier melt, extreme weather events, coral bleaching, range shifts of species, phenological changes; Paris Agreement (2015) — limit warming to 1.5°C above pre-industrial; India: NDC targets, renewable energy, Panchamrit commitments (COP26)
- Phytoremediation: use of plants to remove/degrade/detoxify pollutants from soil and water; Hyperaccumulators (Thlaspi for Zn/Cd; Brassica for Pb; Pteris fern for As); mechanisms: phytoextraction (plants take up metal in biomass), phytostabilisation, rhizofiltration, phytodegradation
- Bioremediation: use of microorganisms to degrade pollutants; Pseudomonas putida (degrades petroleum hydrocarbons — first patented organism: Ananda Chakraborty, 1980); mycoremediation (fungi — Phanerochaete chrysosporium degrades lignin and toxic organics); biostimulation (add nutrients to stimulate native microbes); bioaugmentation (add specific microbes)
Unit 11 — Paper II
U11 Evolution and Behaviour
11.1 Origin of Life
- Chemical evolution: Oparin-Haldane hypothesis (1920s) — primitive Earth had reducing atmosphere (H₂, NH₃, CH₄, H₂O); UV light and lightning provided energy → synthesis of organic molecules → 'primordial soup'
- Miller-Urey experiment (1953): simulated primitive Earth conditions → produced amino acids, sugars, organic acids; demonstrated abiotic synthesis of organic molecules
- RNA World hypothesis: RNA both carries information (like DNA) and has catalytic activity (ribozymes); RNA preceded DNA and proteins; ribosomes still use RNA (23S rRNA) for peptide bond formation — fossil of RNA world
- LUCA (Last Universal Common Ancestor): ~3.5–4 billion years ago; had ribosomes, genetic code, cell membrane; ancestors of Bacteria, Archaea, Eukarya
- Earliest life evidence: stromatolites (3.5 Bya — microbial mats); microfossils (Apex Chert, Australia); molecular fossils; Cyanobacteria responsible for Great Oxidation Event (~2.4 Bya) — O₂ accumulation in atmosphere
11.2 Theories of Evolution
- Lamarckism (Jean-Baptiste Lamarck, 1809): inheritance of acquired characteristics; use and disuse; directed towards greater complexity; disproved (Weismann's experiment — cutting tails of mice for many generations; molecular genetics)
- Darwinism (Charles Darwin, 1859 — On the Origin of Species): Natural Selection; variation exists in populations; individuals with advantageous traits survive and reproduce more (differential fitness); traits heritable → gradual change over generations
- Neo-Darwinism/Modern Synthesis (1930s–40s): integration of Darwinian natural selection with Mendelian genetics; Dobzhansky, Mayr, Huxley, Simpson; population genetics framework (Hardy-Weinberg)
Mechanisms of Evolution
Natural selectionDirectional (favours one extreme — antibiotic resistance in bacteria); Stabilising (favours intermediate — human birth weight); Disruptive (favours both extremes — finch beak size in mixed seed environments)
Genetic driftRandom change in allele frequencies; stronger in small populations; Founder effect (new population from small number of individuals — high allele frequency of rare alleles; Amish, Ellis-van Creveld syndrome); Bottleneck effect (population crash then recovery — North elephant seal — very low genetic diversity)
Gene flow (migration)Movement of alleles between populations via migrating individuals; counteracts divergence; can introduce new alleles; reduces genetic differentiation between populations
MutationUltimate source of new alleles; mutation rate alone insufficient to change allele frequencies rapidly (10⁻⁵ to 10⁻⁶ per gene per generation); provides raw material for selection
Sexual selectionDarwin (1871); traits that increase mating success even if costly for survival; Intrasexual (male-male competition — elk antlers, deer fighting); Intersexual (female choice — peacock tail, bird of paradise plumage)
Molecular driveGabriel Dover; concerted evolution — homogenisation of repetitive sequences across chromosomes and populations; mechanisms: gene conversion, unequal crossing over, transposition; explains why multigene families like rRNA genes are highly similar
Hardy-Weinberg Equilibrium
- In an ideal large random-mating population with no mutation, no migration, no selection → allele and genotype frequencies remain constant
- HWE equations: p + q = 1 (allele frequencies); p² + 2pq + q² = 1 (genotype frequencies — AA, Aa, aa)
- Five assumptions of HWE (if ANY violated → evolution occurs): Random mating; No selection; No mutation; No gene flow; Very large population size
- Application: detect non-random mating (inbreeding — excess homozygotes); estimate carrier frequency (cystic fibrosis — q² = 1/2500, q = 1/50, 2pq ≈ 1/25 carriers)
11.3 Evolutionary Patterns and Speciation
- Species concepts: Biological Species Concept (Mayr — interbreeding natural populations reproductively isolated from others; problematic for fossils, asexual, ring species); Phylogenetic/Cladistic; Ecological; Morphological/Typological
- Speciation types: Allopatric (geographic isolation → independent evolution → reproductive isolation; most common; mountain ranges, rivers, ocean → vicariance; Galapagos finches — island colonisation); Parapatric (adjacent populations; partial barrier; along environmental gradient); Sympatric (in same geographic area — polyploidy in plants, host switching in insects, assortative mating)
- Reproductive isolating mechanisms: Pre-zygotic (habitat, temporal/seasonal, behavioural, mechanical, gametic isolation — prevent mating or fertilisation); Post-zygotic (hybrid inviability, hybrid sterility — mule from horse × donkey, hybrid breakdown)
- Evolutionary patterns: Divergent evolution (common ancestor → different forms; homologous structures — forelimbs of mammals); Convergent evolution (unrelated species → similar form due to similar selection pressure; analogous structures — wings of birds, bats, insects, pterosaurs; eye in vertebrates and octopus); Parallel evolution (related species independently evolve similar traits)
- Mimicry: Batesian (harmless species mimics harmful/toxic species — hoverfly mimics wasp); Müllerian (two or more harmful species share warning coloration — monarch and viceroy butterflies)
- Co-evolution: reciprocal evolutionary change; parasite-host; predator-prey; flowering plants and pollinators (orchid-moth; fig-fig wasp); Red Queen hypothesis — constant evolutionary arms race between species
11.4 Human Evolution
- Primate phylogeny: Order Primates → Prosimii (lemurs, lorises, tarsiers) + Anthropoidea (New World monkeys, Old World monkeys, Apes + Humans)
- Great apes: Pongidae — Orangutan (Pongo), Gorilla, Chimpanzee (Pan — Pan troglodytes and Pan paniscus/bonobos); Humans most closely related to chimpanzees (~98% DNA identity)
- Human fossil record:
| Species | Age (Mya) | Key Features | Discovery |
|---|---|---|---|
| Sahelanthropus tchadensis | 6–7 | Earliest putative hominin; upright foramen magnum position; mosaic of ape and human features | Chad (Toumai skull) |
| Australopithecus afarensis | 3–4 | Lucy skeleton; fully bipedal; small brain (~450 cc); prognathic face; Laetoli footprints (3.6 Mya); no tools | Ethiopia, Tanzania |
| Homo habilis | 2.4–1.4 | Increased brain size (~650 cc); Oldowan stone tools; first Homo; mosaic features | East Africa |
| Homo erectus | 1.9–0.1 | Large brain (~900–1100 cc); Acheulean tools; fire use; migrated out of Africa to Asia (Java man, Peking man) | Africa, Asia, Europe |
| Homo neanderthalensis | 0.4–0.04 | Large brain (~1500 cc); cold adapted; buried dead; Mousterian tools; interbred with H. sapiens; 1–4% Neanderthal DNA in non-African modern humans | Europe, Middle East |
| Homo sapiens | 0.3–present | ~1350 cc brain; advanced language, symbolism, art; Out of Africa 60,000 ya; replaced or interbred with archaic humans | Africa |
- Mitochondrial Eve: most recent common matrilineal ancestor of all living humans; ~150,000–200,000 years ago in Africa; traced via mtDNA (maternal inheritance only); Y-chromosome Adam (~200,000–300,000 ya — most recent common patrilineal ancestor)
- Out of Africa theory: H. sapiens evolved in Africa → single migration out ~60,000–70,000 years ago → spread globally; supported by greatest genetic diversity in Africa (more time for divergence)
11.5 Animal Behaviour (Ethology)
- Innate (fixed) behaviour: genetically programmed; not learned; same in all individuals of species regardless of experience
- Fixed Action Patterns (FAPs): stereotyped, species-specific motor sequences triggered by sign stimulus (releaser); Lorenz and Tinbergen; egg-rolling by Greylag goose; gaping of nestlings; stickleback aggression to red belly
- Sign stimulus and supernormal stimuli: sign stimulus is minimum stimulus needed to trigger FAP; supernormal stimulus is exaggerated version → stronger response (giant egg preferred over own egg by oystercatcher; human fondness for baby faces)
- Tinbergen's four questions (levels of analysis): Causation (mechanism/how?), Ontogeny (development — how does it develop?), Function/Adaptation (why — survival value?), Phylogeny (evolution — how did it evolve?)
Learning Types
HabituationDecreased response to repeated non-harmful stimulus; simplest form of learning; withdrawal reflex in Aplysia (sea slug — basis of cellular learning studies)
Classical conditioningPavlov's dogs; neutral stimulus (bell) paired with unconditioned stimulus (food) → conditioned response (salivation to bell); extinction (remove UCS) and spontaneous recovery
Operant conditioningB.F. Skinner; behaviour shaped by reinforcement (positive/negative) and punishment; Skinner box; shaping; schedules of reinforcement
ImprintingLorenz; critical period learning; goslings imprint on first moving object → species identification; filial imprinting (to mother); sexual imprinting (future mate preference)
Insight learningWolfgang Köhler; chimpanzees stack boxes or use sticks to reach bananas; sudden understanding without trial and error; cognitive problem solving
Latent learningLearning without immediate reinforcement; explored environment (cognitive map); revealed when reinforcement later introduced
Social Behaviour and Communication
- Waggle dance of honeybees (Karl von Frisch — Nobel 1973): worker bee communicates distance and direction of food source; round dance (<100m); waggle dance (>100m); angle of dance from vertical = angle of food from sun; duration of waggle run = distance; figure-eight pattern
- Altruism and kin selection: altruistic behaviour reduces actor's fitness but benefits recipient; Hamilton's Rule: rB > C (r = relatedness coefficient, B = benefit to recipient, C = cost to actor); kin selection — helping relatives passes shared genes; Inclusive fitness = direct fitness + indirect fitness (via helping relatives)
- Eusociality: highest level of social organisation; reproductive division of labour; overlapping generations; cooperative brood care; Hymenoptera (bees, wasps, ants — haplo-diploid: workers r=0.75 to sisters); naked mole rat (only eusocial mammal)
- Reciprocal altruism (Robert Trivers): altruism extended to non-relatives when favour likely to be returned; 'you scratch my back, I'll scratch yours'; requires recognition, memory, repeated interactions; vampire bats blood sharing
- Mating systems: Monogamy (one mate; high parental certainty; many birds); Polygyny (one male, multiple females; sexual dimorphism in males; lions, red deer); Polyandry (one female, multiple males; reversed sexual dimorphism; jacanas, seahorses); Promiscuity (no pair bond)
- Parental investment theory (Robert Trivers): the sex that invests more in offspring (usually female) will be choosier in mate selection; the less investing sex will compete for access
- Pheromones: chemical signals between conspecifics; primer pheromones (alter physiology — queen bee pheromone prevents worker ovary development); releaser pheromones (immediate behaviour — sex attractants in moths, alarm in ants); Bombykol (silk moth sex pheromone — first pheromone identified)
Unit 12 — Paper II
U12 Applied Biology
12.1 Microbial Fermentation and Biotechnology
- Fermentation (industrial): microbial production of useful products; batch, fed-batch, or continuous culture; industrial fermentors (bioreactors) — controlled temperature, pH, aeration, agitation
- Products of microbial fermentation: Ethanol (Saccharomyces cerevisiae — glucose → pyruvate → ethanol + CO₂); Lactic acid (Lactobacillus — yogurt, cheese, sauerkraut, silage); Citric acid (Aspergillus niger); Glutamate (Corynebacterium glutamicum — monosodium glutamate, MSG); Lysine (C. glutamicum — animal feed supplement); Penicillin (Penicillium chrysogenum); Streptomycin (Streptomyces griseus); Insulin (E. coli recombinant); Erythropoietin (CHO cells); tPA
- Antibiotic production: Secondary metabolites from fungi (Penicillium, Cephalosporium) and actinomycetes (Streptomyces — streptomycin, erythromycin, tetracycline, vancomycin, amphotericin B); produced in stationary phase
- SCP (Single Cell Protein): microbial biomass as protein source; Spirulina (cyanobacterium — 60–70% protein); Quorn (Fusarium venenatum — mycoprotein); advantages: rapid growth, use of waste substrates, high protein content
12.2 Immunology Applications
- Vaccines: Active immunisation — stimulate immune memory; Live attenuated (BCG, MMR, oral polio, varicella — more effective, may revert); Killed/inactivated (IPV, hepatitis A, flu injectable — safer); Subunit/recombinant (hepatitis B surface antigen from yeast, acellular pertussis, HPV — VLP); Toxoid (tetanus, diphtheria — inactivated toxin); DNA vaccines; mRNA vaccines (COVID-19 — Pfizer/Moderna — BNT162b2, mRNA-1273)
- Passive immunisation: injection of antibodies; immediate protection, no memory; antivenom (anti-snake venom antibodies); rabies post-exposure; maternal IgG across placenta (first 6 months of life protection)
- ELISA (Enzyme-Linked ImmunoSorbent Assay): Direct, Indirect, Sandwich, Competitive formats; diagnoses HIV (anti-HIV Ab), hepatitis B/C, pregnancy test (hCG), allergy testing, food contaminants; high-throughput; uses enzyme-linked secondary Ab → colorimetric reaction → measured by spectrophotometry
- Western Blot (Immunoblotting): SDS-PAGE → transfer to nitrocellulose membrane → block with milk/BSA → primary Ab → secondary Ab (enzyme/fluorescent) → detection; confirms HIV diagnosis; detects specific proteins; Prion disease diagnosis (PrPˢᶜ); protein size determination
- Flow Cytometry and Immunofluorescence: fluorescence-labelled Abs + cells in flow → laser excites → detectors measure scatter and fluorescence; counts and characterises cells; CD4 count in HIV; cancer immunophenotyping; FACS (fluorescence-activated cell sorting)
- Monoclonal antibodies (mAbs): Köhler and Milstein (Nobel 1984); B cell (immunised mouse) + myeloma cell → hybridoma → clones produce single specificity Ab; Therapeutic mAbs: Trastuzumab/Herceptin (anti-HER2 — breast cancer); Rituximab (anti-CD20 — lymphoma); Adalimumab/Humira (anti-TNFα — rheumatoid arthritis — best-selling drug); Checkpoint inhibitors (anti-PD1 — pembrolizumab/nivolumab; anti-CTLA4 — ipilimumab) — cancer immunotherapy
12.3 Agricultural and Environmental Biotechnology
- Plant tissue culture (PTC): totipotency (Haberlandt's concept — 1902; first demonstrated by Steward with carrot cells, 1958); MS medium (Murashige and Skoog — inorganic salts + vitamins + sucrose + agar); phytohormone balance determines differentiation (high auxin:cytokinin → root; low A:C → shoot; equal → callus)
- Applications of PTC: Micropropagation (clonal propagation of elite plants — orchids, banana, potato); Somatic hybridisation (protoplast fusion — pomato = potato + tomato; not commercially viable but demonstrated); Haploid production (anther culture → doubled haploids → homozygous lines in one generation); Somaclonal variation; Production of secondary metabolites (taxol from Taxus bark vs cell culture)
- Biofertilisers: living organisms that supply nutrients; Rhizobium (N fixation in legumes); Azotobacter, Azospirillum (free-living N fixers); Cyanobacteria (Anabaena — rice fields); Mycorrhizae (P solubilisation, mineral uptake); Phosphate-solubilising bacteria (Bacillus, Pseudomonas); advantages: cheaper, eco-friendly, improve soil health
- Biopesticides: biological pest control; Bt (Bacillus thuringiensis) — Cry proteins (δ-endotoxins) → bind gut epithelium of insects → pore formation → ion imbalance → death; specific to lepidoptera, diptera, coleoptera; used as spray or transgenic crops (Bt cotton, Bt brinjal); NPV (Nuclear Polyhedrosis Virus) for caterpillars; Trichoderma (biocontrol against soil fungi)
- Genetically Modified (GM) crops: herbicide tolerance (Roundup Ready — EPSPS*); insect resistance (Bt crops); disease resistance; enhanced nutrition (Golden Rice — psy + crtI genes from daffodil/bacteria → β-carotene); drought tolerance; extended shelf life (Flavr Savr tomato — anti-sense ACC synthase); India approved Bt cotton (2002) and is considering Bt brinjal, GM mustard
- Metagenomics: study of genetic material from environmental samples (soil, gut, ocean) without culturing; reveals unculturable organisms (99% of environmental microbes cannot be cultured in lab); Human Microbiome Project; Earth Microbiome Project; functional metagenomics for novel enzymes
12.4 Bioresource and Biodiversity Utilisation
- Bioprospecting: systematic search for organisms and molecules that may be useful commercially; often in biodiversity hotspots; concerns about biopiracy (unauthorised use of traditional knowledge — neem, turmeric patent controversies)
- Access and Benefit Sharing (ABS): Nagoya Protocol (2010 — supplementary to CBD); ensures fair sharing of benefits from use of genetic resources with country of origin; India: Biological Diversity Act 2002; National Biodiversity Authority (NBA)
- Traditional knowledge: indigenous communities' knowledge of medicinal plants, agricultural practices; documentation in TKDL (Traditional Knowledge Digital Library — India, to defend against biopiracy); Neem (biopesticide, antifungal — patent challenged); Turmeric (wound healing — patent revoked); Basmati rice (GI — Geographical Indication)
- Blue biotechnology: marine organisms for biotechnology; ω-conotoxins (cone snail — chronic pain treatment); Taq polymerase (Thermus aquaticus — hot spring bacterium); deep-sea microbes (extremophiles — extremozymes for industrial use)
Unit 13 — Paper II
U13 Methods in Biology
13.1 Microscopy
| Technique | Principle | Resolution | Applications |
|---|---|---|---|
| Bright field light microscopy | White light through specimen; contrast from natural pigments or stains | ~200 nm | Histology, basic cell biology; requires staining for most cells |
| Phase contrast microscopy | Differences in refractive index → phase shift → amplitude difference; shows living cells | ~200 nm | Living cell imaging; organelle movement; no staining needed |
| Fluorescence microscopy | Fluorophore-labelled molecules absorb specific wavelength, emit longer wavelength | ~200 nm (diffraction limit); super-resolution <20 nm | Immunofluorescence; GFP-tagged proteins; FISH (Fluorescence In Situ Hybridisation) |
| Confocal microscopy | Pinhole aperture eliminates out-of-focus light; laser scanning; optical sectioning | ~200 nm lateral; better z-axis | 3D reconstruction; thick specimens; live cell imaging; co-localisation |
| STED/PALM/STORM (super-resolution) | Overcome diffraction limit by switching fluorophores on/off; depletion or stochastic activation | 20–50 nm | Single molecule localisation; nanoscale structures; Nobel 2014 (Hell, Moerner, Betzig) |
| Transmission EM (TEM) | Electron beam through ultra-thin section → magnetic lenses → image on screen/film; requires dehydration, heavy metal staining, resin embedding | 0.1–1 nm | Ultrastructure of organelles, viruses, macromolecular complexes |
| Scanning EM (SEM) | Electron beam scans surface; secondary electrons detected → 3D surface image | ~5 nm | Surface morphology of cells, insects, pollen, fossils; requires metal coating |
| Cryo-EM | Flash-frozen specimens preserve native hydrated state; electrons scattered → structure determination; computational averaging of thousands of molecules | Atomic resolution (1.5–3 Å) | Protein complexes, ribosomes, viruses, membrane proteins; Nobel 2017 (Henderson, Frank, Dubochet) |
| Atomic Force Microscopy (AFM) | Cantilever tip scans surface; force between tip and surface measured; maps topography | Sub-nm | DNA imaging; protein unfolding; cell mechanics; works in liquid |
13.2 Separation Techniques
Centrifugation
- Separation based on sedimentation rate (size and density); rate = sedimentation coefficient (Svedberg, S units)
- Differential centrifugation: sequential centrifugation at increasing speeds; 600g (nuclei, unbroken cells) → 10,000g (mitochondria, chloroplasts, lysosomes) → 100,000g (microsomes — ER, Golgi) → supernatant (cytosol)
- Density gradient centrifugation: Sucrose gradient (rate-zonal — separate by size, shape); CsCl gradient (equilibrium/isopycnic — separate by density; used in Meselson-Stahl experiment to separate ¹⁵N/¹⁴N DNA; separate DNA from RNA and protein)
- Ultracentrifugation: up to 500,000g; Sedimentation of ribosomes (70S prokaryotic: 50S + 30S; 80S eukaryotic: 60S + 40S); macromolecule characterisation
Chromatography
| Type | Stationary Phase | Separation Basis | Applications |
|---|---|---|---|
| Ion exchange | Charged resin (cation — negative resin; anion — positive resin) | Charge | Protein purification; amino acid separation; water softening |
| Gel filtration (Size exclusion) | Porous beads (Sephadex, Sepharose) | Size — small molecules enter pores (elute late); large molecules excluded (elute early) | Protein separation by MW; buffer exchange; molecular weight determination |
| Affinity chromatography | Specific ligand (antibody, receptor, substrate analogue) immobilised on beads | Specific binding affinity | Highly specific purification; His-tag (Ni-NTA resin); GST-tag; antibody purification (Protein A/G); hormone receptor isolation |
| HPLC (High Performance Liquid Chromatography) | Micro-beads; high pressure | Polarity, charge, or affinity depending on mode (RP-HPLC — hydrophobicity) | Pharmaceutical analysis; amino acid analysis; nucleotide separation; peptide mapping |
| Thin Layer Chromatography (TLC) | Silica gel on glass/aluminium plate | Polarity — mobile phase (solvent) carries analytes through stationary phase; Rf = distance moved/solvent front | Lipid analysis; drug identification; amino acid separation |
| Gas chromatography (GC) | Inert gas carrier; liquid-coated column | Volatility and boiling point | Volatile organic compound analysis; fatty acid methyl esters; forensic analysis |
| Paper chromatography | Cellulose paper | Polarity; 2D paper chromatography for amino acid separation (Rf values) | Amino acid identification; plant pigment separation |
Electrophoresis
- Agarose gel electrophoresis: DNA/RNA separation by size; negatively charged nucleic acids migrate toward positive pole; smaller molecules move faster; visualised with ethidium bromide (EtBr) or SYBR Green + UV light; DNA ladder as size marker; applications: PCR product analysis, RFLP, Southern blot preparation
- SDS-PAGE (SDS-Polyacrylamide Gel Electrophoresis): SDS denatures proteins + imparts uniform negative charge per unit mass → separation by size only; reducing conditions break disulfide bonds; Staining: Coomassie blue (general), silver stain (high sensitivity), SYPRO Ruby (fluorescent)
- 2D gel electrophoresis: IEF (Isoelectric Focusing — first dimension, separates by pI) + SDS-PAGE (second dimension, separates by size) → each spot = one protein; map of entire proteome; limitations: hydrophobic proteins, dynamic range
- Capillary electrophoresis: high voltage in thin capillary; high resolution; automated; Sanger sequencing readout
- Southern blot: DNA → gel → transfer to membrane → hybridise with probe → detect; detects specific DNA sequences/mutations; RFLP analysis
- Northern blot: RNA → gel → membrane → probe → detects mRNA; size and abundance of specific mRNA
- Western blot: protein → SDS-PAGE → membrane → primary Ab → secondary Ab-enzyme → ECL detection; detects specific proteins; see immunology applications above
13.3 Molecular Biology Techniques
- RT-PCR (Reverse Transcription PCR): RNA → cDNA (reverse transcriptase) → PCR amplification; detects RNA viruses (HIV, COVID-19); measures gene expression (semi-quantitative)
- qPCR (Quantitative/Real-Time PCR): fluorescent signal (SYBR Green or TaqMan probe) measured each cycle; quantifies DNA/RNA in real time; Cᵧ value (cycle at which fluorescence crosses threshold) → lower Cᵧ = more template; gene expression quantification (ΔΔCᵧ method)
- Gene expression analysis: Microarray (DNA chips — thousands of probes on chip; hybridise labelled cDNA from two conditions; red/green ratio = differential expression; older technology); RNA-seq (NGS-based; digital counting; wider dynamic range; detects novel transcripts, splice variants; replaced microarrays)
- ChIP-seq (Chromatin Immunoprecipitation + Sequencing): crosslink protein-DNA → shear chromatin → immunoprecipitate with Ab against specific protein (TF, histone modification) → reverse crosslinks → sequence → maps genomic binding sites; identifies enhancers, promoters, histone modification patterns
- ATAC-seq: Assay for Transposase-Accessible Chromatin — maps open chromatin regions; transposase cuts and inserts sequencing adaptors preferentially in accessible chromatin → identifies active regulatory elements
- Protein sequencing: Edman degradation (sequential removal of N-terminal amino acids — phenylisothiocyanate; determines sequence; automated; up to ~60 residues); Mass spectrometry (trypsin digestion → peptides → MALDI-TOF or ESI-MS/MS → de novo sequencing or database matching)
- X-ray crystallography: protein/nucleic acid crystals → X-ray diffraction → electron density map → atomic model; determined DNA structure (Franklin's photo 51); many enzyme structures; PDB (Protein Data Bank — 200,000+ structures)
- NMR spectroscopy: solution structure; dynamics; protein-ligand interactions; limited to smaller proteins (<50 kDa); useful for intrinsically disordered proteins
- Two-Hybrid System (Yeast Two-Hybrid, Y2H): detecting protein-protein interactions in vivo; bait protein fused to DNA-BD; prey protein fused to AD; interaction → reporter gene expression; limitations: false positives, requires nuclear localisation, can't study toxic interactions
- FRET (Förster Resonance Energy Transfer): distance between fluorophores <10 nm → energy transfer from donor to acceptor; detects molecular interactions, conformational changes in live cells; single-molecule FRET (sm-FRET)
13.4 Antibody-Based Detection Methods
- ELISA (Enzyme-Linked ImmunoSorbent Assay): see above; highly sensitive and specific; OD (optical density) measured at specific wavelength (450 nm for TMB substrate)
- Radioimmunoassay (RIA): uses radioactive isotope-labelled antigen (¹²⁵I); competitive binding; highly sensitive; now replaced by ELISA in most applications due to radiation concerns
- Immunofluorescence: Direct (fluorophore-labelled primary Ab) or Indirect (unlabelled primary + fluorophore-secondary — amplification); co-localisation studies; fixed (formaldehyde) or live cell imaging; confocal for 3D
- Immunoprecipitation (Co-IP): antibody + cell lysate → bead pull-down → wash → elute → western blot; detects protein-protein interactions in native conditions; ChIP uses this principle with DNA
13.5 Animal and Cell Culture Models
- Cell culture: primary cells (directly from tissue — limited divisions); cell lines (transformed — immortal; HeLa — first human cell line, Henrietta Lacks 1951, HPV-18 oncogene; CHO cells — biopharmaceutical production; 3T3 fibroblasts; Jurkat — T cell line)
- Stem cell culture: ESC (embryonic stem cells — require feeder cells, LIF in mouse; 3D organoids); iPSC (reprogrammed; patient-specific; disease modelling); maintenance of pluripotency vs directed differentiation
- Model organisms: E. coli (gene regulation, molecular biology); Saccharomyces cerevisiae (cell cycle — Hartwell Nobel 2001; protein secretion); Caenorhabditis elegans (fixed cell lineage; apoptosis; RNAi; Brenner, Sulston, Horvitz Nobel 2002); Drosophila melanogaster (genetics — Morgan Nobel 1933; development — Nüsslein-Volhard/Wieschaus Nobel 1995; behaviour); Danio rerio (zebrafish — transparent embryo; vertebrate development; ENU mutagenesis screens); Mus musculus (mouse — gene knockout, transgenic; disease models); Arabidopsis thaliana (plant genomics; small genome; rapid life cycle; T-DNA insertion mutants)
- 3R Principle (animal experimentation): Replacement (use non-animal alternatives where possible); Reduction (use minimum number of animals); Refinement (minimise suffering, improve procedures); IAEC (Institutional Animal Ethics Committee) oversight required in India (CPCSEA regulation)
CPCSE (Committee for the Purpose of Control and Supervision of Experiments on Animals) governs animal experimentation in India under the Prevention of Cruelty to Animals Act 1960 and Breeding and Experiments on Animals Rules 1998. OECD Guidelines for testing of chemicals guide international standards. Always mention ethical clearance in experimental answers.
Extra Section — Exam Intelligence
PYQ Previous Year Question Analysis (2013–2024)
PYQ.1 Most Frequently Asked Topics
Life Sciences shares significant overlap with CSIR-NET JRF Life Sciences. Practice CSIR-NET questions alongside UPSC PYQs for maximum depth and coverage.
| Topic | Frequency | Paper | Typical Question Pattern |
|---|---|---|---|
| CRISPR-Cas9 mechanism and applications | ⭐⭐⭐ Every year since 2016 | Both | "Explain the mechanism of CRISPR-Cas9 genome editing" / "Applications of CRISPR in medicine" |
| Cell signaling — RTK, GPCR, PI3K/Akt, MAPK | ⭐⭐⭐ | Paper I | "Describe the Ras/MAPK signaling cascade" / "Role of second messengers in cell communication" |
| DNA replication — enzymes and mechanism | ⭐⭐⭐ | Paper I | "Describe eukaryotic DNA replication with enzymes" / "End-replication problem and telomerase" |
| Gene regulation (operon + eukaryotic) | ⭐⭐⭐ | Paper I | "Explain lac operon regulation" / "Chromatin remodelling in eukaryotic gene expression" |
| Apoptosis pathways (intrinsic and extrinsic) | ⭐⭐⭐ | Paper I | "Describe intrinsic pathway of apoptosis" / "Role of Bcl-2 family in apoptosis" |
| DNA repair mechanisms | ⭐⭐ | Paper I | "Explain different types of DNA repair with enzymes" / "Xeroderma pigmentosum and NER" |
| Enzyme kinetics (Michaelis-Menten, inhibition) | ⭐⭐⭐ | Paper I | "Distinguish competitive and non-competitive inhibition" / "Derive Michaelis-Menten equation" |
| Plant hormones — ethylene and ABA | ⭐⭐ | Paper I | "Role of ethylene in fruit ripening" / "ABA-mediated stomatal closure mechanism" |
| Hardy-Weinberg principle and population genetics | ⭐⭐⭐ | Paper II | "State HWE conditions and prove the principle" / "Calculate carrier frequency in a population" |
| Natural selection and speciation | ⭐⭐ | Paper II | "Types of natural selection with examples" / "Allopatric vs sympatric speciation" |
| Transgenic organisms and GM crops | ⭐⭐ | Paper II | "How are transgenic plants developed?" / "Bt crops — mechanism and concerns" |
| Biodiversity and conservation (India context) | ⭐⭐ | Paper II | "Biodiversity hotspots of India" / "In situ and ex situ conservation strategies" |
| Human evolution and fossil record | ⭐⭐ | Paper II | "Trace the evolution of Homo sapiens" / "Significance of Australopithecus in human evolution" |
| Recombinant DNA technology (PCR, vectors, cloning) | ⭐⭐⭐ | Paper II | "Applications of PCR in medicine and forensics" / "Types of vectors used in cloning" |
| Immunology — monoclonal antibodies, vaccines | ⭐⭐ | Paper II | "Production of monoclonal antibodies" / "Mechanism of mRNA vaccines" |
| Ecological succession and energy flow | ⭐⭐ | Paper II | "Primary vs secondary succession with examples" / "Trophic levels and energy transfer" |
| Stem cells — types and therapeutic uses | ⭐⭐ | Paper I | "Classify stem cells by potency" / "Therapeutic potential of iPSCs" |
| Translation mechanism — ribosomes and genetic code | ⭐⭐ | Paper I | "Describe eukaryotic translation initiation" / "Properties of genetic code" |
| Photosynthesis — Z-scheme and Calvin cycle | ⭐⭐ | Paper I | "Compare C3, C4, and CAM pathways" / "Describe light reactions and photophosphorylation" |
| Animal behaviour — altruism, kin selection, mating | ⭐⭐ | Paper II | "Explain kin selection with Hamilton's rule" / "Waggle dance communication in bees" |
PYQ.2 Year-wise High-Value Questions (Selected)
| Year | Paper | Question (Paraphrased) | Marks |
|---|---|---|---|
| 2024 | I | Describe the mechanism of CRISPR-Cas9 and its applications in therapeutic genome editing. Discuss ethical concerns. | 20 |
| 2024 | II | Explain Hardy-Weinberg equilibrium. What are the evolutionary forces that violate it? Solve numerical problem. | 20 |
| 2023 | I | Describe the intrinsic and extrinsic pathways of apoptosis. How do Bcl-2 family proteins regulate these? | 20 |
| 2023 | II | Write an account of GM crops in India. Critically evaluate Bt cotton's impact on Indian agriculture. | 20 |
| 2022 | I | Explain Michaelis-Menten kinetics. How do competitive and non-competitive inhibitors alter Km and Vmax? | 15 |
| 2022 | II | Describe the role of natural selection in speciation. Distinguish allopatric from sympatric speciation with examples. | 20 |
| 2021 | I | Describe eukaryotic DNA replication with emphasis on the roles of key enzymes. How is the end-replication problem solved? | 20 |
| 2021 | II | Write notes on monoclonal antibodies, their production and therapeutic applications. | 15 |
| 2020 | I | Explain the Ras-MAPK signaling cascade. How do oncogenic Ras mutations lead to cancer? | 20 |
| 2020 | II | Describe biodiversity hotspots with reference to India. What are the threats and conservation strategies? | 20 |
| 2019 | I | Compare C3, C4, and CAM photosynthesis. What are the ecological advantages of C4 plants? | 20 |
| 2019 | II | Trace the evolutionary history of Homo sapiens from Australopithecines. What evidence supports Out of Africa theory? | 20 |
| 2018 | I | Describe the lac operon. How is it regulated by glucose and lactose? What is catabolite repression? | 20 |
| 2018 | II | Explain types of natural selection. What is molecular drive and how does it differ from selection? | 15 |
| 2017 | I | Describe the structure and function of the ribosome. Explain the elongation cycle of translation. | 20 |
| 2017 | II | What is PCR? Describe its principle and applications in diagnosis and forensics. | 15 |
| 2016 | I | Describe nucleosome structure and histone modifications. How do they regulate gene expression? | 20 |
| 2016 | II | Describe kin selection and reciprocal altruism. How do they explain the evolution of social behaviour? | 15 |
| 2015 | I | Explain the mechanism of ATP synthesis by the F₀F₁-ATP synthase. How does the proton gradient drive synthesis? | 20 |
| 2015 | II | What are stem cells? Classify them by potency and describe the therapeutic applications of iPSCs. | 20 |
Extra Section — Last-Mile Revision
QR Quick Revision — Facts, Nobel Prizes, Mnemonics and Tables
QR.1 Nobel Prizes — Life Sciences (Must Know)
1953 — Watson & Crick
Double helix structure of DNA. Franklin's X-ray diffraction data (Photo 51) used without credit — ethical controversy.
1958 — Beadle & Tatum
One gene-one enzyme hypothesis (Neurospora crassa nutritional mutants). Also Lederberg for bacterial genetics.
1962 — Watson, Crick, Wilkins
Nobel Prize for DNA structure (Franklin died 1958, not eligible).
1965 — Jacob & Monod
Operon model of gene regulation (lac operon). Also Lwoff for phage lysogeny.
1975 — Dulbecco, Baltimore, Temin
Reverse transcriptase (Temin and Baltimore independently). Central dogma violation — RNA→DNA possible.
1977 — Roberts & Sharp
Split genes (introns) — awarded 1993. RNA splicing discovery changed understanding of gene structure.
1978 — Arber, Smith, Nathans
Restriction enzymes — foundation of recombinant DNA technology.
1980 — Berg, Gilbert, Sanger
Berg: recombinant DNA; Gilbert and Sanger: DNA sequencing methods. Sanger won TWO Nobels (1958 protein sequencing).
1983 — Barbara McClintock
Mobile genetic elements (transposons — 'jumping genes') in maize. First proposed 1950, ignored; Nobel 30+ years later.
1984 — Köhler & Milstein
Monoclonal antibodies (hybridoma technology). Jerne for immune system theories. Most impactful medical biotechnology.
1993 — Mullis
PCR — Polymerase Chain Reaction. Smith for site-directed mutagenesis. Most used molecular biology technique.
1995 — Nüsslein-Volhard & Wieschaus
Genetic control of early embryonic development (Drosophila body plan genes — segment polarity, gap, pair-rule genes).
1997 — Prusiner
Prions — proteinaceous infectious particles. Caused CJD, BSE, scrapie. Central dogma exception (no nucleic acid).
2001 — Hartwell, Hunt, Nurse
Cell cycle regulation — cyclins and CDKs. Hartwell (yeast), Nurse (fission yeast), Hunt (cyclin discovery).
2002 — Brenner, Sulston, Horvitz
C. elegans model — organ development and programmed cell death (apoptosis). Complete cell lineage mapped.
2006 — Fire & Mello
RNA interference (RNAi) discovery in C. elegans. Revolutionised gene silencing and therapeutics.
2009 — Blackburn, Greider, Szostak
Telomere structure and telomerase enzyme. Ageing and cancer connections.
2012 — Gurdon & Yamanaka
Gurdon: nuclear reprogramming (frog); Yamanaka: iPSCs (4 factors). Mature cells can be reprogrammed to pluripotency.
2014 — Hell, Moerner, Betzig
Super-resolution microscopy (STED, PALM, STORM) — overcame Abbe diffraction limit.
2017 — Henderson, Frank, Dubochet
Cryo-EM for high-resolution structure determination of biomolecules in solution.
2020 — Doudna & Charpentier
CRISPR-Cas9 genome editing. First Nobel for two women without male co-laureate. Most important biotechnology of 21st century so far.
QR.2 Mnemonics
Essential Amino Acids — PVT TIM HaLL
- Phenylalanine, Valine, Threonine
- Tryptophan, Isoleucine, Methionine
- Histidine, Leucine, Lysine
Krebs Cycle Intermediates
- Citrate → Isocitrate (aconitase)
- → α-Ketoglutarate → Succinyl-CoA
- → Succinate → Fumarate → Malate → OAA
- Mnemonic: Citrus Is Key: Succinyl-Succinate Found Mainly Overall
DNA Repair Types
- Direct — O⁶-methylG reversal (MGMT)
- Base Excision — BER (glycosylase → AP endo)
- Nucleotide Excision — NER (UV dimers, XP)
- Mismatch — MMR (Lynch syndrome)
- Homologous Recombination — HR (BRCA1/2)
- NHEJ — Non-Homologous End Joining (error-prone)
Adopter Categories and Biodiversity Threats
- HIPPO (threats to biodiversity):
- Habitat loss (most important)
- Invasive species
- Pollution
- Population (human overpopulation)
- Overexploitation (hunting, fishing)
Meiosis Prophase I — LZPDD
- Leptotene — chromosomes condense
- Zygotene — synapsis; synaptonemal complex
- Pachytene — crossing over (chiasmata)
- Diplotene — SC dissolves; lampbrush in oocytes
- Diakinesis — maximal condensation; terminalization
Wnt signalling (with Wnt present)
- Frizzled + LRP → Dishevelled activated
- Destruction complex INHIBITED
- β-catenin NOT phosphorylated → accumulates
- β-catenin enters nucleus + TCF/LEF
- Target genes: Cyclin D1, c-Myc → proliferation
- APC loss (colon cancer) → same outcome without Wnt
QR.3 Key Numbers and Values
ATP yield from glucose
~30–32 ATP total: 2 (glycolysis net) + 2 (TCA substrate-level) + ~26–28 (oxidative phosphorylation). NADH = 2.5 ATP; FADH₂ = 1.5 ATP (current values, not older 3/2).
Ribosome sizes
Prokaryotic 70S (50S + 30S); Eukaryotic cytoplasmic 80S (60S + 40S); Mitochondrial/Chloroplast ~70S (similar to prokaryotic — endosymbiotic origin). Svedberg units (S) are NOT additive.
DNA replication speed
E. coli: ~1000 bp/sec; Eukaryotes: ~30–100 bp/sec (slower but many more origins). E. coli genome (4.6 Mb) replicated in ~40 min from single ori.
Human genome
~3.2 billion bp (haploid); ~20,000–25,000 protein-coding genes; only ~1.5–2% codes for protein; ~45% repetitive sequences; mtDNA = 16,569 bp; 23 pairs of chromosomes.
GFR (Glomerular Filtration Rate)
~125 mL/min = 180 L/day filtered; only ~1.5 L excreted as urine; 99% reabsorbed. CKD: GFR <60 mL/min for >3 months.
Heart output
Cardiac output = SV × HR = 70 mL × 70 bpm = ~5 L/min at rest; up to 20–25 L/min during intense exercise. SA node: 70 bpm (dominant pacemaker).
Lung volumes
Tidal volume 500 mL; Total Lung Capacity ~6000 mL; Vital Capacity ~4800 mL; FEV₁/FVC >0.7 = normal; <0.7 = obstructive (COPD, asthma).
Chromosome numbers
Humans 46 (2n=46; n=23); Drosophila 8 (2n=8); C. elegans 12 (hermaphrodite); Bread wheat 42 (hexaploid 6×=6n=42); Ophioglossum reticulatum (fern) 1440 — highest known.
India biodiversity
7th largest country area; 8% global species; 33% endemic flowering plants; 4 hotspots; 17 megadiverse nations; 91,212 animal species, 45,500 plant species; 54 tiger reserves (2024); tiger population 3,167 (2022 census).
Biodiversity hotspot criteria
≥1500 endemic vascular plant species AND ≥70% primary habitat already lost; 36 global hotspots covering 2.5% of Earth's land but 60% of world's plant, reptile, amphibian, bird, mammal species.
QR.4 Molecular Biology Quick Reference
| Process | Template | Product | Direction | Primer needed? | Key enzyme |
|---|---|---|---|---|---|
| DNA Replication | DNA | DNA | 5'→3' synthesis | Yes (RNA primer) | DNA Pol δ, ε (euk) |
| Transcription | DNA (template strand 3'→5') | RNA | 5'→3' synthesis | No | RNA Pol II (mRNA) |
| Translation | mRNA (5'→3') | Protein | N→C terminus | No (Met-tRNA starts) | Ribosome (rRNA) |
| Reverse Transcription | RNA | DNA | 5'→3' DNA synthesis | Yes (tRNA or oligo-dT) | Reverse Transcriptase |
| PCR amplification | dsDNA | dsDNA (amplified) | 5'→3' | Yes (oligonucleotide primers) | Taq Pol (thermostable) |
QR.5 Cell Signaling Receptors — Quick Reference
| Ligand | Receptor Type | Second Messenger/Pathway | Downstream Effects |
|---|---|---|---|
| Adrenaline (β receptor) | GPCR (Gs) | cAMP → PKA | Glycogenolysis, lipolysis, bronchodilation, ↑ HR |
| Acetylcholine (muscarinic M2) | GPCR (Gi) | ↓ cAMP; ↑ K⁺ conductance | Slows HR; hyperpolarisation |
| Insulin | RTK (insulin receptor — heterotetrameric α₂β₂) | IRS-1 → PI3K → PIP₃ → Akt | GLUT4 translocation, glycogenesis, lipogenesis, inhibit apoptosis |
| EGF | RTK (EGFR/ErbB1) | Grb2-SOS → Ras → Raf → MEK → ERK | Cell proliferation, differentiation, migration |
| TGF-β | Ser/Thr kinase receptor | SMAD2/3 phosphorylation → SMAD4 complex | Growth inhibition, EMT, extracellular matrix production |
| Testosterone/Oestrogen | Nuclear receptor (intracellular) | Direct gene transcription (HRE) | Secondary sexual characters, bone density, metabolism |
| Notch | Juxtacrine (transmembrane) | γ-secretase → NICD → CSL/RBP-Jκ | Cell fate determination, lateral inhibition |
| Wnt | Frizzled + LRP | β-catenin stabilisation → TCF/LEF | Cell proliferation, stem cell maintenance, embryonic patterning |
QR.6 Hormones and Control — Quick Reference
| Hormone | Gland | Type | Receptor location | Key effect / Mnemonic |
|---|---|---|---|---|
| TSH | Anterior pituitary | Glycoprotein | Cell surface (GPCR) | Stimulates thyroid T3/T4 production and secretion |
| Cortisol | Adrenal cortex | Steroid | Nuclear (GR) | Anti-inflammatory; gluconeogenesis; immune suppression; stress; "the S hormone" (Stress, Sugar, Salt, Sex — all adrenal) |
| Aldosterone | Adrenal cortex | Steroid | Nuclear (MR) | Na⁺ retention, K⁺ excretion (remember: Aldosterone in kidney: saves Na, loses K) |
| PTH | Parathyroid | Peptide | Cell surface (GPCR) | ↑ Ca²⁺ — bone resorption + renal reabsorption + 1α-hydroxylase activation (↑ active Vit D) |
| Insulin | Pancreas β-cell | Peptide | Cell surface (RTK) | Only hypoglycaemic hormone; promotes ANABOLISM (store energy); GLUT4 to membrane |
| Glucagon | Pancreas α-cell | Peptide | Cell surface (GPCR-Gs) | Opposes insulin; glycogenolysis, gluconeogenesis (raises blood glucose); ketogenesis |
| ADH (Vasopressin) | Hypothalamus (posterior pituitary) | Peptide | V1 (vasoconstriction), V2 (kidney) | V2 → cAMP → AQP2 insertion → ↑ water reabsorption → concentrated urine |
| Oxytocin | Hypothalamus (posterior pituitary) | Peptide | Cell surface | Uterine contraction (labour); milk ejection (let-down reflex); bonding; "the love hormone" |
Extra Section — Exam Strategy
AW Answer Writing Strategy for Life Sciences Optional
AW.1 Directive Words and Answer Structure
| Directive | What Examiner Wants | Life Sciences Specific Tip |
|---|---|---|
| Describe/Explain | Detailed, step-by-step account with mechanism | Always include: substrate → enzyme/protein → product; regulatory steps; use equations where applicable |
| Discuss | Multiple aspects, perspectives, evidence | Include: classical experiments that established the concept + current understanding; exceptions if any |
| Compare/Distinguish | Point-by-point differences (and similarities) | Draw a comparison TABLE — saves words, looks professional, easy to mark |
| Critically evaluate | Strengths AND limitations; evidence for and against | Structure: present the concept → supporting evidence → limitations/critiques → balanced conclusion |
| With the help of a diagram | DIAGRAM IS MANDATORY — marks deducted if absent | Label every component; use arrows for direction; indicate sites of regulation; clean pencil diagram in ink-based answer |
| Outline/Briefly describe | Key points without extensive detail | Bullet points or numbered list acceptable; highlight only key steps/concepts; do not elaborate |
| Account for | Provide reasons/mechanisms/evidence | Explain WHY, not just WHAT; include molecular basis for the observation asked about |
AW.2 High-Scoring Answer Templates
Template 1: Molecular Mechanism Question (e.g., CRISPR, Apoptosis, Signaling)
- Para 1: Introduction — define the system; historical context and discovery (with Nobel if applicable); significance
- Para 2: Components — list and briefly describe all key molecular players (proteins, RNAs, small molecules)
- Para 3: Step-by-step mechanism — numbered or flowchart format; precise molecular events; regulation highlighted
- Para 4: DIAGRAM — labelled schematic; essential for full marks; do not skip even if question doesn't explicitly say so for mechanisms
- Para 5: Applications/Significance — medical, agricultural, biotechnological applications
- Para 6: Limitations or current challenges
- Conclusion: 2–3 sentences; future directions
Template 2: Comparison Question (e.g., C3/C4/CAM; prokaryote/eukaryote transcription)
- Para 1: Brief introduction defining both terms being compared
- Table: 8–10 parameters (location/organism, process steps, enzymes, products, regulation, efficiency, examples, clinical/agricultural relevance)
- Para 2: Key similarities (often overlooked but important)
- Para 3: Functional significance of differences
- Diagram: where relevant, show both processes side by side
- Conclusion: summary of which is 'better' in what context
Template 3: Ecology/Evolution Question
- Para 1: Define the concept precisely; historical context (Darwin, Hardy-Weinberg, Hutchinson, etc.)
- Para 2: Mathematical/quantitative expression where applicable (HWE: p² + 2pq + q² = 1; Hamilton's rule: rB > C; Lotka-Volterra)
- Para 3: Specific examples — prefer real, well-known examples (Galapagos finches, Kettlewell moths, Isle Royale wolves, Western Ghats)
- Para 4: Indian context or UPSC-relevant applications (biodiversity, conservation, India-specific data)
- Para 5: Critical evaluation — assumptions, limitations, controversies
- Conclusion: relevance to conservation, management, or policy
Template 4: Biotechnology/Applied Biology
- Para 1: Background — why was this technique/organism/approach developed? What problem does it solve?
- Para 2: Principle — the underlying biological mechanism
- Para 3: Protocol/Method — step-by-step with specific reagents, enzymes, conditions; flow diagram preferred
- Para 4: Applications — minimum 4–5 applications across different domains (medicine, agriculture, forensics, industry)
- Para 5: Advantages and limitations
- Para 6: Ethical/biosafety concerns (GEAC — Genetic Engineering Appraisal Committee; ICMR guidelines; biosafety levels)
- Conclusion: current status in India + future potential
AW.3 Must-Draw Diagrams
Paper I Diagrams
- Fluid Mosaic Model of membrane
- Nucleosome structure (8 histones + DNA)
- DNA replication fork (enzymes labeled)
- Transcription bubble (eukaryotic Pol II)
- Ribosome A, P, E sites + tRNA
- Lac operon — induced and repressed states
- TCA cycle (all 8 steps with enzymes)
- ETC (Complexes I–IV + ATP synthase)
- Z-scheme of photosynthesis
- Ras-MAPK signaling cascade
- Intrinsic apoptosis pathway (Bax → Cytochrome c → Apoptosome)
- Cell cycle (G₁, S, G₂, M) + CDK/Cyclin levels
- Meiosis I and II key stages
- Spemann organiser in frog gastrulation
- CRISPR-Cas9 mechanism (sgRNA + PAM + DSB)
Paper II Diagrams
- O₂-Hb dissociation curve (Bohr effect, 2,3-BPG)
- Nephron anatomy with reabsorption sites
- Menstrual cycle (FSH, LH, oestrogen, progesterone)
- Dihybrid cross (Punnett square + ratios)
- Linkage and recombination (crossover diagram)
- Hardy-Weinberg (allele frequency pie chart)
- Phylogenetic tree of life (3 domains)
- Plasmodium life cycle (in mosquito + human)
- Food web diagram (with energy % transfer)
- Nitrogen cycle (complete)
- Population growth curves (J vs S shape)
- Natural selection types (graphs)
- Allopatric speciation flowchart
- PCR — 3 steps diagram (denaturation, annealing, extension)
- SDS-PAGE and Western blot comparison
AW.4 Exam-Day Strategy
- First 15 minutes: Read all questions carefully; mark your sure-shot 4 questions; plan which optional to attempt for 5th question; allocate time (20-mark questions: 25–30 min each; 10-mark: 12–15 min each)
- Diagram first strategy: For mechanism questions, draw the diagram FIRST before writing; it organises your thoughts and ensures you don't miss the diagram at the end
- Start with strongest question: Attempt the question you know best first; momentum and confidence; examiner sees your best work early
- Quantitative questions: Show ALL working; even if final answer is wrong, partial credit for correct steps; check dimensional analysis; state formula before applying values
- Keywords: Use technical terms correctly and precisely — examiners look for domain-specific vocabulary (e.g., 'Ku70/Ku80 heterodimer' not just 'proteins'; 'PCNA sliding clamp' not just 'processivity factor')
- Indian context bonus: Always add India-specific examples where possible (India's first test tube baby, Bt cotton controversies, Western Ghats biodiversity, NIN/NCBS research) — differentiates your answer
- End each answer clearly: A brief conclusion restating the main point; examiners often skim to the end
30-Day Revision Plan
| Week | Paper I Focus | Paper II Focus | Daily Target |
|---|---|---|---|
| Week 1 (Days 1–7) | Molecules + Cellular Organisation (U1, U2) | Animal Physiology (U7) | 2 mechanisms in full detail + 1 diagram per day |
| Week 2 (Days 8–14) | Fundamental Processes + Cell Signaling (U3, U4) | Inheritance Biology (U8) | 3 PYQs/day; write 1 full 20-mark answer |
| Week 3 (Days 15–21) | Developmental Biology + Plant Physiology (U5, U6) | Ecology + Evolution (U10, U11) | Focus on diagrams + Nobel prize connections |
| Week 4 (Days 22–28) | Full Paper I revision: PYQs | Applied Biology + Methods (U12, U13) | Mock paper (5 questions, 3 hours); mark yourself |
| Final 2 days | Quick Revision only: Nobel table, diagrams list, key numbers, PYQ patterns. NO new learning. | Sleep 8 hours; light exercise; hydrate | |
AW.5 Interdisciplinary Connections for Bonus Marks
- Molecular biology + Medicine: Link BRCA1/2 mutations to cancer and CRISPR therapy; p53 dysfunction to tumour biology; telomerase to ageing and cancer
- Cell signaling + Disease: Oncogenic Ras → colorectal, lung, pancreatic cancer; EGFR mutations → lung cancer (gefitinib target); BCR-Abl → CML (imatinib/Gleevec first targeted therapy)
- Genetics + Ethical dimensions: Human genome editing (germline vs somatic); He Jiankui scandal (CCR5 editing in embryos); designer babies; genetic discrimination; Genetic Data Protection
- Ecology + Climate change: Range shifts of species northward; phenological mismatch (flowers early → pollinators not synchronised); coral bleaching (thermal stress → symbiotic algae expulsion); India: glacial retreat in Himalayas affecting agriculture
- Evolution + Antibiotic resistance: Classic example of natural selection in real time; MRSA in hospital settings; resistance to antimalarials (Plasmodium falciparum resistance to chloroquine, artemisinin); WHO priority pathogens
- Plant physiology + Agriculture: Dwarf wheat (Green Revolution — semi-dwarfing Rht genes — GA-insensitive DELLA proteins); photoperiodism in rice — IR8 (short-day) vs Basmati (photoperiod-sensitive); nitrogen fixation and biofertilisers
- Methods + Real-world application: PCR in COVID diagnosis (RT-PCR); CRISPR in sickle cell treatment (Casgevy — FDA 2023); monoclonal antibodies in cancer immunotherapy; flow cytometry in HIV monitoring (CD4 count)
Comments 0
Leave a Comment